abl
reach
consensu
committe
member
definit
clinic
research
strategi
acut
bacteri
rhinosinus
chronic
rhinosinus
cr
without
polyp
cr
polyp
allerg
fungal
rhinosinus
afr
divers
opinion
express
whether
rhinosinus
would
best
character
infect
inflammatori
condit
current
understand
term
infect
inflamm
therefor
includ
discuss
consensu
confer
multipl
viewpoint
discuss
gener
agreement
one
caus
factor
fulli
explain
adequ
account
patholog
manifest
clinic
heterogen
rhinosinus
histopatholog
speak
inflammatori
compon
disord
manifest
mix
mononuclear
inflammatori
cell
infiltr
neutrophil
predomin
acut
diseas
eosinophil
predomin
chronic
diseas
addit
evolut
thought
move
away
notion
cr
explain
basi
sinu
ostial
obstruct
persist
bacteri
infect
appreci
cr
signific
inflammatori
compon
might
caus
simultan
independ
variou
factor
evid
vari
potenti
sourc
condit
discuss
includ
restrict
possibl
role
persist
infect
factor
cr
includ
biofilm
osteiti
allergi
disord
immun
intrins
factor
upper
airway
superantigen
staphylococcu
aureu
cr
nasal
polyp
colon
fungi
induc
sustain
eosinophil
inflamm
metabol
perturb
aspirin
sensit
emphas
sever
mechan
might
act
simultan
independ
given
patient
thu
document
review
variou
caus
factor
rhinosinus
highlight
area
role
rhinosinus
controversi
new
inform
emerg
variou
physician
author
individu
section
serv
background
inform
controversi
definit
present
later
articl
document
also
present
classif
scheme
cr
basi
current
knowledg
consensu
opinion
furthermor
discuss
subject
object
measur
use
diagnosi
evalu
rhinosinus
import
factor
design
clinic
trial
discuss
ultim
consensu
definit
rhinosinus
put
forth
acut
presum
bacteri
rhinosinus
cr
without
polyp
cr
polyp
classic
afr
initi
propos
made
clinic
trial
design
includ
outlin
suggest
subject
object
assess
applic
studi
group
conclud
promot
research
acut
rhinosinus
cr
essenti
better
understand
pathophysiolog
diseas
need
studi
design
evalu
potenti
therapeut
modal
rhinosinus
well
appropri
outcom
studi
must
care
consid
consensu
recommend
base
clinic
expertis
particip
turn
base
review
understand
clinic
literatur
repres
posit
regulatori
agenc
pharmaceut
compani
much
work
need
done
definit
studi
design
rhinosinus
recommend
although
document
repres
essenti
begin
process
develop
recommend
studi
design
studi
therapeut
modal
treatment
rhinosinus
respons
collabor
group
futur
group
decid
consensu
use
term
rhinosinus
instead
sinus
throughout
document
decis
base
fact
sinus
almost
alway
accompani
concurr
nasal
airway
inflamm
mani
case
sinus
preced
rhiniti
symptom
therefor
believ
use
term
rhinosinus
accur
describ
spectrum
infecti
inflammatori
condit
previous
group
term
sinus
group
endors
adopt
previous
develop
definit
sinu
allergi
health
partnership
task
forc
rhinosinus
rhinosinus
group
disord
character
inflamm
mucosa
nose
paranas
sinus
acut
rhinosinus
cr
without
nasal
polyposi
cr
nasal
polyposi
classic
afr
diagnost
criteria
outlin
includ
pattern
symptom
defin
one
typic
symptom
necessari
diagnos
diseas
object
criteria
requir
measur
monitor
progress
determin
clinic
efficaci
also
suggest
hope
establish
consensu
definit
recommend
recogn
expert
diagnosi
assess
rhinosinus
provid
clinician
research
tool
necessari
develop
implement
appropri
clinic
studi
serv
catalyst
research
rhinosinus
rhinosinus
increas
preval
incid
estim
affect
approxim
million
patient
unit
state
year
caus
signific
physic
symptom
neg
affect
qualiti
life
qol
substanti
impair
daili
function
advanc
exist
definit
describ
manifest
rhinosinus
discuss
elsewher
sinus
prove
difficult
due
part
numer
caus
condit
includ
viral
bacteri
fungal
allerg
caus
addit
mani
patient
seemingli
idiopath
diseas
rhinosinus
commonli
divid
acut
chronic
form
major
categori
list
intern
classif
diseasesninth
revis
sixth
edit
although
class
ie
subacut
recurr
acut
acut
exacerb
chronic
commun
acquir
bacteri
nosocomi
describ
elsewher
medic
literatur
acut
rhinosinus
usual
infecti
natur
wherea
chronic
diseas
might
result
wide
rang
process
relat
complex
health
care
problem
practic
constraint
primari
focu
articl
establish
clear
definit
acut
rhinosinus
cr
research
advanc
exist
definit
clinic
care
goal
achiev
basi
evid
literatur
consensu
opinion
committe
member
propos
definit
clear
need
research
form
rhinosinus
enough
understood
pathophysiolog
condit
without
better
understand
safer
effect
treatment
option
develop
date
clinic
research
includ
drug
trial
focus
acut
rhinosinus
reason
limit
number
therapeut
trial
cr
includ
lack
widespread
accept
exist
definit
disord
acknowledg
difficulti
establish
caus
condit
result
clinician
left
use
empir
guidelin
best
judgment
choos
intervent
treatment
cr
likewis
lack
evidencebas
guidelin
aid
develop
success
rhinosinus
clinic
trial
notwithstand
need
addit
research
wide
held
agreement
care
consider
paramet
trial
design
outcom
studi
requir
start
point
variou
caus
factor
play
role
rhinosinus
includ
microorgan
allerg
nonallerg
immunolog
inflamm
noninfecti
nonimmunolog
caus
infect
defin
invas
multipl
microorgan
within
steril
host
tissu
inflamm
seri
cellular
molecular
respons
design
elimin
foreign
agent
promot
repair
damag
tissu
histolog
pattern
inflamm
function
least
factor
natur
incit
agent
time
observ
immun
statu
host
common
cold
involv
nasal
passag
paranas
sinus
cold
nasal
fluid
contain
virus
bacteria
inflammatori
mediat
blown
sinus
produc
inflamm
infect
result
mucos
edema
cellular
infiltr
mucu
thicken
mean
exocytosi
mucin
numer
goblet
cell
sinu
epithelium
sinu
infect
caus
one
bacteria
high
densiti
least
coloni
form
unit
cfu
ml
commonli
isol
bacteria
patient
rhinosinus
includ
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
bacteri
rhinosinus
classifi
acut
subacut
chronic
depend
durat
symptom
role
bacteri
infect
children
adult
cr
controversi
bacteri
superantigen
biofilm
osteiti
might
play
import
role
cr
warrant
studi
afr
distinct
clinic
subset
cr
patient
posit
evid
allergi
fungu
colon
allerg
mucin
major
case
patient
afr
typic
demonstr
characterist
gross
product
eosinophil
mucin
contain
noninvas
fungal
hypha
nasal
polyposi
specif
radiograph
find
immunocompet
allergi
cultur
fungi
present
afr
might
dramat
give
rise
acut
visual
loss
gross
facial
dysmorphia
complet
nasal
obstruct
often
present
subtl
recent
studi
suggest
fungi
might
play
altern
role
develop
cr
wherebi
patient
mount
innat
immun
respons
colon
fungi
nonigemedi
mechan
respons
hypothes
lead
local
eosinophil
infiltr
inflamm
tissu
injuri
concept
eosinophil
fungal
rhinosinus
encompass
patient
cr
document
allerg
immunolog
factor
associ
develop
rhinosinus
clinic
perenni
allerg
rhiniti
predispos
condit
acut
bacteri
rhinosinus
histolog
cr
without
nasal
polyp
crssnp
character
predominantli
neutrophil
inflamm
lesser
contribut
eosinophil
wherea
cr
nasal
polyp
crswnp
character
eosinophil
inflamm
eotaxin
could
play
role
latter
process
neither
total
ige
concentr
eosinophil
cation
protein
ecp
concentr
nasal
polyp
differ
atop
versu
nonatop
subject
suggest
discord
system
allerg
phenotyp
local
inflammatori
mechan
lead
eosinophil
inflamm
nasal
polyp
np
role
propos
ige
specif
staphylococcalderiv
superantigen
pathogenesi
cr
associ
nasal
polyp
rhinosinus
inflammatori
overact
underact
autonom
nerv
pathway
abnorm
leukotrien
product
respons
nocicept
dysfunct
local
irrit
caus
gastroesophag
reflux
demonstr
select
subset
patient
rhinosinus
could
predispos
pathogenesi
cr
defect
mucociliari
clearanc
antibodi
defici
syndrom
predispos
rhinosinus
aspirinassoci
respiratori
diseas
also
predispos
rhinosinus
examin
histolog
middl
turbin
tissu
subject
polypoid
versu
nonpolypoid
diseas
might
allow
distinct
entiti
sampl
patient
crssnp
versu
crswnp
gener
show
differ
pattern
cellular
content
gross
histolog
chang
within
tissu
especi
regard
fibrosi
edema
mucos
line
crssnp
character
basement
membran
thicken
goblet
cell
hyperplasia
limit
subepitheli
edema
promin
fibrosi
mononuclear
cell
infiltr
histomorpholog
character
crswnp
reveal
frequent
epitheli
damag
thicken
basement
membran
mostli
edemat
sometim
fibrot
stromal
tissu
reduc
number
vessel
gland
virtual
neuron
structur
characterist
symptom
sign
crswnp
includ
nasal
congest
facial
painpressureful
postnas
drainag
hyposmiaanosmia
presenc
bilater
np
histolog
np
typic
show
inflammatori
infiltr
increas
number
eosinophil
least
process
might
contribut
variabl
degre
inflammatori
process
crswnp
latephas
allerg
inflamm
respons
airborn
allergen
tcell
activ
product
ifng
respons
fungal
antigen
hypha
sinu
mucu
tcell
activ
cytokin
product
local
ige
product
respons
bacteri
superantigen
dysregul
sinu
epithelium
overproduct
chemokin
rant
numer
subject
object
assess
measur
use
diagnosi
evalu
rhinosinus
includ
symptom
qol
score
rhinoscop
examin
imag
nasalsinu
challeng
relev
rhinosinus
symptom
sever
time
cours
document
characterist
symptom
sign
rhinosinus
includ
nasal
congest
facial
painpressureful
anterior
postnas
drainag
hyposmiaanosmia
symptom
list
necessarili
differ
patient
acut
versu
chronic
diseas
symptom
present
patient
rhiniti
evid
sinus
analog
scale
use
report
individu
symptom
sever
score
total
rhinosinus
sever
score
global
sever
score
overal
qol
score
effect
current
past
treatment
complet
thorough
assess
morbid
associ
rhinosinus
evalu
treatment
imper
physic
social
emot
function
problem
associ
condit
measur
valid
way
investig
strive
report
qualityoflif
qol
data
fashion
clinic
meaning
sever
valid
rhinosinus
outcom
measur
instrument
seem
best
suit
particular
research
question
select
anterior
rhinoscopi
basic
tool
physic
examin
relat
determin
exist
patholog
sinonas
passag
best
evalu
patient
decongest
topic
decongest
howev
even
method
examin
nasal
passag
beyond
anterior
portion
limit
nasal
endoscopi
help
identifi
erythema
edema
polyp
polypoid
swell
crust
eosinophil
mucin
mucopu
frank
pu
deep
nasal
caviti
cultur
obtain
endoscop
less
invas
associ
less
morbid
howev
techniqu
found
equival
antral
punctur
children
sinu
infect
although
rhinosinus
diagnos
major
patient
use
histori
physic
examin
includ
endoscopi
patient
persist
sinu
diseas
often
requir
imag
studi
studi
absolut
requir
patient
undergo
function
endoscop
sinu
surgeri
comput
tomographi
ct
major
role
manag
rhinosinus
defin
anatomi
sinus
surgeri
aid
diagnosi
manag
recurr
rhinosinus
cr
although
magnet
reson
imag
mri
display
boni
anatomi
ct
provid
excel
display
mucosa
better
ct
distinguish
bacterialvir
inflammatori
diseas
fungal
concret
nasalsinu
challeng
use
defin
pathophysiolog
rhinosinus
interact
nose
sinus
well
lower
airway
nasal
challeng
also
use
confirm
presenc
allergi
assess
nasal
threshold
respons
studi
mediat
inflammatori
cell
cytokin
associ
rhinosinus
integr
airway
syndrom
also
call
chronic
inflammatori
respiratori
syndrom
wide
spectrum
sever
low
end
manifest
clinic
evid
form
rhiniti
high
end
manifest
includ
asthma
possibl
rhinosinus
strong
link
upper
lower
airway
allerg
rhiniti
nonallerg
rhiniti
risk
factor
asthma
allerg
rhiniti
almost
ubiquit
asthma
even
absenc
nasal
symptom
nasal
mucosa
patient
asthma
show
evid
inflamm
rhiniti
asthmat
patient
tend
sever
rhiniti
nonasthmat
patient
moreov
allerg
reaction
inflammatori
consequ
appear
propag
system
therefor
link
nose
sinus
lower
airway
might
consid
system
process
agreement
definit
histopatholog
diagnost
criteria
import
prelud
select
appropri
design
clinic
studi
rhinosinus
efficaci
treatment
modal
rhinosinus
must
demonstr
adequ
wellcontrol
studi
show
intervent
effect
claim
factor
consid
develop
protocol
studi
includ
primari
secondari
studi
object
overal
studi
design
basi
dose
select
rout
administr
studi
popul
inclusionexclus
criteria
control
subject
safeti
efficaci
outcom
variabl
statist
consider
power
studi
exampl
prospect
choic
end
point
import
decis
design
clinic
studi
efficaci
end
point
studi
form
basi
approv
treatment
modal
clinic
relev
valid
j
allergi
clin
immunol
volum
number
rhinosinus
increas
preval
incid
estim
affect
approxim
million
patient
unit
state
year
caus
signific
physic
symptom
neg
affect
qol
substanti
impair
daili
function
advanc
exist
definit
describ
manifest
rhinosinus
discuss
elsewher
sinus
prove
difficult
due
part
numer
caus
condit
includ
viral
bacteri
fungal
allerg
caus
addit
mani
patient
seemingli
idiopath
diseas
rhinosinus
commonli
divid
acut
chronic
form
major
categori
list
intern
classif
diseasesninth
revis
sixth
edit
although
class
ie
subacut
recurr
acut
acut
exacerb
chronic
commun
acquir
bacteri
nosocomi
describ
elsewher
medic
literatur
acut
rhinosinus
usual
infecti
natur
wherea
chronic
diseas
might
result
wide
rang
process
relat
complex
health
care
problem
practic
constraint
primari
focu
articl
establish
clear
definit
acut
rhinosinus
cr
research
advanc
exist
definit
clinic
care
goal
achiev
basi
evid
literatur
consensu
opinion
intern
leader
propos
definit
clear
need
research
form
rhinosinus
enough
understood
pathophysiolog
condit
without
better
understand
safer
effect
treatment
option
develop
date
clinic
research
includ
drug
trial
focus
acut
rhinosinus
reason
limit
number
therapeut
trial
cr
includ
lack
widespread
accept
exist
definit
disord
acknowledg
difficulti
establish
caus
condit
result
clinician
left
use
empir
guidelin
best
judgment
choos
intervent
treatment
cr
likewis
lack
evidencebas
guidelin
aid
develop
success
rhinosinus
clinic
trial
notwithstand
need
addit
research
wide
held
agreement
care
consider
paramet
trial
design
outcom
studi
requir
start
point
prefac
section
term
infect
inflamm
discuss
defin
infect
typic
induc
inflammatori
respons
defin
variou
way
although
import
note
choos
defin
infect
microbi
phenomenon
character
inflammatori
respons
presenc
microorgan
other
believ
true
infect
defin
invas
multipl
microorgan
tissu
addit
hold
infect
distinct
colon
immun
respons
develop
diseas
host
j
gwaltney
person
commun
inflamm
seri
cellular
molecular
respons
design
elimin
foreign
agent
promot
repair
damag
tissu
begin
reaction
blood
vessel
lead
accumul
fluid
leukocyt
extravascular
tissu
increas
evid
addit
infect
immunolog
inflammatori
respons
play
major
role
caus
pathophysiolog
cr
articl
infect
distinguish
inflamm
along
tradit
concept
tissu
invas
acknowledg
howev
histopatholog
evid
distinct
form
rhinosinus
care
studi
addit
hotli
debat
hypothes
explain
cr
relat
colon
sinonas
mucosa
microorgan
host
respons
presenc
eg
superantigensproduc
aureu
colon
fungi
substanti
concern
identifi
rhinosinus
infect
alon
might
promot
continu
widespread
use
antimicrobi
agent
current
evid
support
use
particularli
chronic
diseas
limit
obviou
concern
contribut
increas
rate
antimicrobi
resist
histolog
pattern
inflamm
function
least
factor
natur
incit
agent
time
observ
immun
statu
host
time
tradit
defin
basi
clinic
onset
durat
respons
specif
inflamm
refer
acut
sign
symptom
appear
minut
hour
subacut
span
day
week
chronic
occur
week
month
main
patholog
characterist
acut
inflamm
exud
fluid
plasma
protein
edema
emigr
leukocyt
predominantli
neutrophil
chronic
inflamm
histolog
associ
presenc
lymphocyt
macrophag
occasion
eosinophil
basophil
prolifer
blood
vessel
fibrosi
tissu
necrosi
clear
distinct
acut
chronic
inflamm
somewhat
artifici
numer
overlap
pattern
inflamm
despit
evolutionari
benefit
inflamm
repair
alter
balanc
proinflammatori
antiinflammatori
mediat
lead
harm
effect
microorgan
rhinosinus
although
symptom
common
cold
recogn
sinc
antiqu
first
cold
viru
rhinoviru
discov
within
year
discoveri
replic
strategi
atom
structur
viru
determin
rhinoviru
enter
bodi
nose
mean
either
contamin
finger
larg
airborn
particl
viru
transport
mucu
stream
adenoid
region
nasopharynx
reach
area
special
lymphoepitheli
cell
cell
overli
lymphoid
follicl
lymphoepitheli
cell
rich
rhinoviru
receptor
intercellular
adhes
molecul
seri
event
effici
one
central
featur
pathogenesi
infect
caus
rhinoviru
nonimmun
individu
nasal
passag
unabl
clear
inactiv
viru
exampl
nonimmun
healthi
young
adult
challeng
drop
rhinoviru
nose
individu
becam
infect
howev
three
quarter
becam
infect
symptom
ill
reflect
inappar
infect
rate
similar
observ
natur
condit
initi
rhinoviru
infect
effici
mechan
also
occur
quit
rapidli
intranas
rhinoviru
challeng
suscept
volunt
newli
produc
viru
recov
nasal
secret
within
hour
amount
time
requir
rhinoviru
replic
cell
cultur
also
studi
symptom
observ
appear
rel
short
time
sore
throat
nasal
obstruct
rhinorrhea
report
within
hour
viru
challeng
recogn
common
cold
involv
nasal
passag
also
paranas
sinus
fig
sinu
ct
scan
obtain
young
adult
earli
common
cold
reveal
frequent
abnorm
sinu
caviti
abnorm
observ
maxillari
sinu
patient
ethmoid
sinu
frontal
sphenoid
subset
patient
underw
repeat
ct
scan
week
later
origin
chang
resolv
spontan
resolut
correspond
upper
respiratori
tract
infect
find
sinu
abnorm
cold
confirm
adult
children
natur
find
debat
one
explan
develop
thick
exud
adher
sinu
wall
tenac
materi
move
ciliari
action
epithelium
sinu
caviti
contain
high
concentr
goblet
cell
exocytosi
larg
amount
mucin
might
occur
cell
stimul
import
determin
natur
abnorm
implic
understand
pathogenesi
process
appropri
approach
treatment
whatev
natur
selflimit
process
repres
viral
rhinosinus
occur
part
common
cold
unusu
find
ct
scan
sinu
patient
fresh
common
cold
close
evalu
explor
possibl
caus
sinu
abnorm
common
cold
scan
show
maxillari
sinu
fill
unquestion
air
bubbl
give
frothi
appear
materi
fig
sinu
ct
scan
taken
day
later
show
typic
find
associ
viral
sinus
exud
contain
air
bubbl
led
hypothesi
patient
nasal
fluid
blown
infundibulum
sinu
produc
multipl
air
bubbl
fluid
exit
narrow
lumen
infundibulum
pressur
enter
rel
larg
sinu
caviti
later
materi
believ
thicken
mean
exocytosi
mucin
coalesc
form
exud
intranas
pressur
measur
volunt
quiet
respir
nose
blow
sneez
cough
determin
nasal
fluid
might
propel
sinu
caviti
mean
sd
maxim
intranas
pressur
mm
hg
nose
blow
mm
hg
sneez
mm
hg
cough
bout
fig
sneez
cough
increas
intranas
pressur
greater
observ
quiet
respir
contrast
medium
place
pharynx
volunt
blew
nose
sneez
cough
investig
pressur
effect
nasal
passag
nose
blow
ct
scan
sinus
obtain
contrast
medium
appear
one
sinus
subject
nose
blow
sneez
cough
fig
j
allergi
clin
immunol
volum
number
calcul
reveal
middl
meatu
fill
viscou
fluid
singl
nose
blow
propel
ml
materi
maxillari
sinu
find
might
explain
origin
sinu
caviti
abnorm
cold
also
might
explain
abnorm
usual
irregular
occurr
among
variou
sinus
one
sinu
might
consider
involv
anoth
might
perfectli
normal
summari
find
support
hypothesi
cold
nasal
fluid
contain
virus
bacteria
inflammatori
mediat
might
blown
sinus
produc
inflamm
infect
thicken
mean
exocytosi
mucin
numer
goblet
cell
sinu
epithelium
thu
ct
abnorm
observ
viral
rhinosinus
could
result
inflamm
alon
viral
infect
cell
sinu
epithelium
sinu
punctur
studi
patient
acut
communityacquir
rhinosinus
sinu
aspir
yield
rhinoviru
yield
influenza
viru
yield
parainfluenza
viru
yield
adenoviru
known
whether
actual
repres
viral
replic
sinu
caviti
sinu
aspir
yield
virus
bacteria
criteria
defin
case
viral
rhinosinus
lack
howev
attent
given
tri
defin
situat
viral
agent
sole
caus
case
viral
rhinosinus
estim
complic
secondari
bacteri
infect
howev
recogn
studi
ever
conduct
sensit
specif
variou
clinic
find
evalu
comparison
standard
posit
viral
bacteri
sinu
aspir
cultur
current
clinic
diagnost
criteria
larg
proport
case
acut
communityacquir
bacteri
rhinosinus
use
antimicrobi
treatment
wide
accept
today
includ
cold
better
wors
day
convers
current
clinic
diagnost
criteria
viral
rhinosinus
includ
cold
begin
resolv
day
better
week
day
onset
purpos
research
criteria
standard
diagnosi
viral
rhinosinus
posit
viru
cultur
detect
viral
nucleic
acid
cell
sinu
epithelium
indic
activ
viral
replic
bacteri
infect
although
paranas
sinus
believ
steril
normal
circumst
upper
respiratori
tract
specif
nose
nasopharynx
heavili
colon
normal
flora
normal
nasal
flora
adult
children
includ
coagulaseneg
staphylococci
cn
corynebacterium
speci
aureu
children
organ
frequent
cultur
nasal
caviti
includ
pneumonia
catarrhali
h
influenza
normal
nasalsinu
flora
patient
cr
role
bacteri
pathogen
cr
poorli
defin
cr
mucos
respons
bacteri
colon
bacteri
infect
otherwis
normal
host
like
differ
acut
rhinosinus
given
possibl
differ
criteria
defin
colon
infect
probabl
need
establish
microbiolog
acut
rhinosinus
children
microbiolog
paranas
sinu
infect
anticip
accord
age
patient
clinic
present
immunocompet
host
despit
substanti
preval
clinic
import
rhinosinus
childhood
studi
microbiolog
acut
subacut
rhinosinus
pediatr
patient
rel
limit
use
studi
design
similar
one
describ
investig
univers
virginia
investig
microbiolog
acut
sinus
pediatr
patient
conduct
children
hospit
pittsburgh
patient
elig
studi
year
age
present
one
clinic
pictur
onset
either
persist
sever
respiratori
symptom
sinu
radiograph
perform
elig
children
either
present
maxillari
sinu
aspir
use
transnas
approach
perform
children
present
either
persist
sever
symptom
significantli
abnorm
sinu
radiograph
bacteria
high
densiti
recov
bacteri
isol
rel
order
preval
shown
tabl
pneumonia
common
follow
close
catarrhali
h
influenza
h
influenza
catarrhali
might
blactamas
produc
therebi
amoxicillin
resist
approxim
third
pneumonia
also
exhibit
intermedi
high
resist
penicillin
h
influenza
found
sinu
aspir
like
found
infect
middl
ear
caviti
almost
alway
nontyp
organ
reflect
frequent
colon
nasopharynx
contrast
h
influenza
type
b
singl
anaerob
bacteri
speci
peptostreptococcu
isol
staphylococci
recov
mix
infect
heavi
growth
bacteri
speci
occasion
found
patient
bilater
maxillari
sinus
discord
bacteri
cultur
result
patient
one
sinu
aspir
posit
wherea
neg
remain
patient
differ
bacteri
speci
recov
b
microbiolog
subacut
rhinosinus
children
sign
symptom
children
subacut
rhinosinus
describ
youngster
evalu
context
sever
differ
compar
trial
antimicrobi
therapi
children
persist
respiratori
symptom
ie
nasal
discharg
cough
last
day
children
gener
good
health
minim
constitut
complaint
except
respiratori
symptom
intermitt
fever
complaint
patient
rare
document
time
present
children
previous
receiv
one
cours
antimicrobi
agent
case
either
fail
respond
antimicrobi
agent
improv
slightli
experienc
recurr
symptom
cessat
antibiot
tabl
ii
show
bacteri
speci
cultur
children
predomin
organ
pneumonia
h
influenza
catarrhali
c
microbiolog
cr
children
studi
microbiolog
cr
children
tabl
iii
three
studi
prospect
retrospect
one
studi
maxillari
sinu
sampl
mean
transnas
aspir
common
criterion
evalu
symptom
least
day
attempt
made
steril
nose
investig
quantit
bacteria
rare
perform
part
result
frequent
need
irrig
maxillari
sinu
obtain
suffici
materi
cultur
studi
patient
receiv
antibiot
time
cultur
obtain
studi
normal
nasal
flora
usual
organ
recov
ie
cn
viridian
streptococci
difficult
know
patholog
signific
ascrib
cn
remain
studi
usual
sinu
pathogen
recov
case
ie
h
influenza
pneumonia
catarrhali
h
influenza
common
especi
true
criteria
entri
includ
purul
secret
remain
children
organ
recov
except
studi
perform
brook
associ
anaerob
rare
recov
children
cr
patient
acut
exacerb
cr
character
persist
intermitt
episod
purul
nasal
discharg
usual
microorgan
associ
acut
sinus
caus
howev
patient
chronic
persist
rhinosinus
nasal
congest
nonspecif
rhinorrhea
cough
alon
combin
role
bacteri
agent
less
clear
organ
recov
low
densiti
frequent
recov
time
patient
receiv
antibiot
organ
suscept
lack
quantit
organ
also
complic
interpret
middl
meatu
children
known
colon
usual
sinu
pathogen
persist
symptom
despit
multipl
cours
appropri
antimicrobi
agent
mani
children
counter
notion
bacteri
infect
signific
compon
cr
observ
support
hypothesi
bacteri
infect
minor
role
mani
children
cr
microbiolog
acut
communityacquir
rhinosinus
adult
adult
bacteriolog
inform
deriv
mainli
cultur
mucu
obtain
mean
aspir
maxillari
sinu
access
paranas
sinus
although
certainti
cultur
maxillari
sinu
extrapol
paranas
sinus
find
sinu
punctur
studi
perform
unit
state
abroad
provid
fairli
similar
result
gener
sinu
infect
caus
singl
bacteri
isol
high
densiti
case
bacteri
speci
high
densiti
recov
import
caus
acut
communityacquir
rhinosinus
adult
pneumonia
nontyp
h
influenza
tabl
iv
speci
account
bacteri
isol
one
remark
chang
observ
gwaltney
colleagu
increas
preval
blactamaseproduc
h
influenza
first
decad
blactamasemedi
resist
rare
howev
half
strain
h
influenza
blactamas
produc
increas
blactamaseposit
h
influenza
last
year
mechan
resist
appear
stabil
less
isol
next
frequenc
streptococci
pneumococci
streptococc
b
strain
anaerob
bacteri
speci
role
anaerob
acut
communityacquir
diseas
variabl
although
anaerob
bacteria
remark
role
chronic
sinu
diseas
establish
acut
sinu
diseas
account
acut
case
aris
primari
dental
patholog
aureu
streptococcu
pyogen
uncommon
caus
acut
rhinosinus
children
adult
actual
role
aureu
might
occasion
exagger
surrog
nasal
cultur
substitut
sinu
aspir
although
uncommon
aureu
pyogen
may
caus
seriou
intracrani
suppur
rare
subperiost
orbit
abscess
complic
acut
rhinosinus
e
microbiolog
nosocomi
rhinosinus
patient
nosocomi
rhinosinus
usual
requir
extend
period
intens
care
postop
patient
burn
victim
patient
sever
trauma
involv
prolong
endotrach
nasogastr
intub
nasotrach
intub
provid
substanti
higher
risk
nosocomi
sinus
orotrach
intub
nosocomi
rhinosinus
develop
approxim
patient
requir
nasotrach
intub
day
contrast
communityacquir
rhinosinus
sampl
taken
hospit
patient
usual
contain
pathogen
gramneg
enter
eg
pseudomona
aeruginosa
klebsiella
pneumonia
enterobact
speci
proteu
mirabili
serratia
marcescen
gramposit
cocci
occasion
streptococci
staphylococci
whether
organ
actual
caus
origin
sinu
diseas
unclear
howev
might
repres
postsurg
colon
environ
impair
mucociliari
transport
caus
presenc
foreign
bodi
nasal
caviti
tabl
v
three
studi
prospect
import
prospect
investig
assur
patient
identifi
cultur
process
standard
fashion
cn
common
aerob
isol
studi
often
accompani
aureu
viridian
streptococci
absenc
quantit
perform
gram
stain
almost
studi
prohibit
assess
densiti
organ
accompani
inflammatori
respons
although
cn
tradit
discount
pathogen
acut
rhinosinus
cr
role
pathogen
bodi
site
well
document
review
hsu
et
al
neutropen
sepsi
infect
indwel
cathet
burn
patient
frequent
bacteri
recoveri
swab
obtain
middl
meatu
healthi
subject
suggest
bacteria
commens
like
contamin
nadel
et
al
suggest
differ
might
quantit
natur
unusu
situat
larg
number
white
blood
cell
organ
present
gram
stain
heavi
growth
cn
possibl
true
infect
entertain
surpris
isol
studi
gramneg
enter
rod
includ
p
aeruginosa
k
pneumonia
p
mirabili
enterobact
speci
escherichia
coli
rare
found
cultur
middl
meatu
obtain
healthi
individu
isol
symptomat
patient
suggest
possibl
organ
caus
gramneg
organ
might
colon
secondarili
infect
underli
defect
host
defens
impair
mucociliari
clearanc
nasal
polyp
patient
cr
cystic
fibrosi
correspond
transport
defect
furthermor
frequent
use
antibiot
patient
might
promot
emerg
gramneg
bacteri
colon
infect
excel
illustr
complex
deal
microbiolog
cr
assess
role
anaerob
condit
isol
anaerob
critic
depend
cultur
techniqu
studi
use
optim
techniqu
isol
frequenc
organ
recov
patient
studi
vari
zero
everi
number
review
seri
studi
anaerob
found
primarili
investig
finegold
et
al
brook
frazier
reconcili
studi
other
signific
recoveri
anaerob
unclear
support
role
anaerob
bacteria
chronic
maxillari
sinus
finegold
et
al
found
recurr
sign
symptom
twice
frequent
cultur
show
anaerob
bacteri
count
greater
cfu
ml
role
support
detect
antibodi
igg
anaerob
organ
commonli
recov
sinu
aspir
fusobacterium
nucleatum
prevotella
intermedia
antibodi
level
organ
decreas
patient
respond
therapi
cure
decreas
therapi
fail
anaerob
identifi
chronic
sinus
primarili
special
techniqu
cultiv
use
predomin
isol
identifi
pigment
prevotella
fusobacterium
peptostreptococcu
speci
predomin
aerob
bacteria
aureu
catarrhali
haemophilu
speci
sever
studi
aerob
anaerob
blactamaseproduc
bacteria
isol
one
third
patient
studi
blactamaseproduc
bacteria
identifi
aureu
haemophilu
speci
prevotella
speci
fusobacterium
speci
sinc
total
patient
cr
evalu
studi
use
method
adequ
recoveri
anaerob
bacteria
anaerob
recov
patient
variabl
recoveri
might
result
differ
methodolog
use
transport
cultiv
patient
popul
geographi
previou
antimicrobi
therapi
investig
argu
cr
repres
repeatedli
damag
mucos
line
lost
normal
state
steril
author
ascrib
major
role
bacteria
patholog
cr
unless
acut
exacerb
character
purul
nasal
discharg
obvious
work
need
resolv
discrep
data
suggest
strategi
would
conduct
prospect
investig
patient
care
identifi
character
cultur
gram
stain
obtain
use
asept
techniqu
rigor
standard
handl
specimen
least
semiquantit
cultur
method
use
densiti
bacteria
assess
inflammatori
infiltr
character
neutrophil
eosinophil
mark
differ
pathogen
mechan
g
new
insight
role
bacteria
cr
bacteri
superantigen
number
bacteria
virus
fungi
produc
exotoxin
sometim
refer
enterotoxin
abl
activ
lymphocyt
crosslink
mhc
ii
molecul
antigenpres
cell
variabl
beta
vb
region
tcell
receptor
exotoxin
term
superantigen
activ
subpopul
repres
lymphocyt
contrast
classic
antigen
activ
less
lymphocyt
addit
superantigen
also
act
classic
antigen
lead
concomit
gener
antisuperantigen
antibodi
includ
antibodi
ige
isotyp
potenti
role
superantigen
aureu
pathogenesi
nasal
polyposi
suggest
discuss
section
factor
involv
nasal
polyposi
biofilm
biofilm
commun
organ
microorgan
surround
glycocalyx
frequent
form
artifici
damag
biolog
surfac
organ
live
biofilm
rel
impervi
host
defens
antimicrobi
agent
bacteri
biofilm
elegantli
demonstr
anim
model
otiti
media
use
scan
electron
microscopi
confoc
microscopi
possibl
bacteri
biofilm
could
contribut
cr
formal
studi
possibl
theoret
attract
might
help
explain
clinic
situat
patient
frequent
neg
cultur
improv
symptomat
receiv
antibiot
relaps
antibiot
withdrawn
biofilm
plankton
bacteria
leav
biofilm
caus
symptom
suscept
host
defens
antibiot
howev
biofilm
rel
impervi
antimicrobi
agent
never
erad
mechan
debrid
appear
mechan
resolv
biofilm
refractori
patient
might
explain
improv
surgeri
irrig
osteiti
role
bone
date
bacteri
organ
identifi
bone
either
human
subject
anim
model
cr
howev
chronic
osteomyel
known
organ
scarc
difficult
identifi
whether
bacteria
induc
boni
remodel
associ
inflamm
whether
truli
infect
bone
unknown
area
increas
bone
densiti
boni
thicken
frequent
seen
ct
scan
area
chronic
inflamm
might
marker
chronic
inflammatori
process
howev
initi
phase
sever
cr
effect
frequent
appear
rarefact
boni
ethmoid
partit
one
studi
bone
specimen
patient
cr
healthi
control
subject
label
tetracyclin
mean
oral
ingest
week
later
demeclocyclin
bone
underw
biopsi
day
complet
second
antibiot
cours
patient
cr
significantli
greater
remodel
activ
control
group
demonstr
signific
separ
line
fluoresc
result
tetracyclin
bone
also
evalu
bone
turnov
semiquantit
qualit
appli
techniqu
histomorphometri
indic
evalu
includ
bone
volum
osteoid
surfac
erod
surfac
fibrosi
osteoblast
surfac
tetracyclin
label
statist
signific
differ
obtain
bone
turnov
seen
cr
group
similar
seen
patient
osteomyel
trauma
rabbit
studi
experiment
induc
pseudomona
maxillari
sinus
perloff
et
al
demonstr
bone
becom
involv
adjac
involv
maxillari
sinu
also
inflamm
typic
spread
haversian
canal
might
result
bone
chang
consist
degre
chronic
osteomyel
distanc
primari
infect
studi
khalid
et
al
use
pseudomona
speci
aureu
rabbit
studi
demonstr
similar
result
bone
involv
note
anim
ipsilater
side
infect
specimen
clear
osteonecrosi
identifi
inflammatori
bone
chang
also
note
contralater
side
anim
inflamm
caus
welldefin
chang
bone
rabbit
adjac
infect
distanc
primari
site
inflamm
compat
histolog
diagnosi
chronic
osteomyel
inflammatori
spread
within
bone
appear
occur
result
welldefin
chang
haversian
canal
lead
first
widen
canal
increas
vascular
inflammatori
cellular
collect
within
canal
later
fibrosi
involv
area
certainli
possibl
chang
confirm
patient
might
least
part
explain
cr
rel
resist
medic
therapi
fungal
colonizationsensit
afr
distinct
clinic
subset
cr
patient
posit
evid
fungal
allergi
fungu
colon
allerg
mucin
major
case
patient
afr
typic
demonstr
characterist
gross
product
eosinophil
mucin
contain
noninvas
fungal
hypha
nasal
polyposi
characterist
radiograph
find
immunocompet
allergi
cultur
fungi
present
afr
might
dramat
give
rise
acut
visual
loss
gross
facial
dysmorphia
complet
nasal
obstruct
often
present
subtl
recent
studi
suggest
fungi
play
altern
role
develop
cr
wherebi
patient
becom
sensit
colon
fungi
nonigemedi
mechan
sensit
hypothes
lead
local
eosinophil
chemotaxi
inflamm
tissu
injuri
concept
eosinophil
fungal
rhinosinus
encompass
patient
cr
spectrum
fungal
involv
cr
run
benign
colon
potenti
lifethreaten
invas
diseas
fungal
colon
nose
paranas
sinus
appear
common
find
normal
diseas
state
although
consider
debat
preval
colon
fungal
colon
presum
due
ubiquit
natur
fungal
spore
ambient
air
propens
spore
germin
nasal
sinu
mucu
rare
circumst
lead
macroscop
fungal
prolifer
form
fungu
ball
formerli
refer
mycetoma
saprophyt
growth
fungu
case
fungal
mycelia
accumul
occupi
avail
space
within
nose
paranas
sinus
absenc
signific
mucos
inflamm
treatment
simpli
direct
toward
extirp
offend
fungal
growth
occur
commonli
case
fungu
ball
microscop
quantiti
fungal
hypha
sinu
mucu
elicit
intens
local
immun
respons
afr
give
rise
pathognomon
featur
diseas
name
presenc
allerg
mucin
describ
import
realiz
afr
fungal
ball
repres
noninvas
form
fungal
rhinosinus
must
distinguish
invas
form
invas
fungal
rhinosinus
often
acut
fulmin
diseas
carri
high
mortal
rate
acut
fulmin
invas
fungal
rhinosinus
usual
caus
fungi
absidia
speci
aspergillu
speci
basidiobolu
speci
mucor
speci
rhizopu
speci
howev
patient
whose
immunolog
defici
mild
unappar
invas
fungal
rhinosinus
might
run
indol
chronic
cours
diagnosi
made
basi
histolog
evid
invas
fungi
nose
paranas
sinus
present
week
manag
requir
repeat
surgic
debrid
correct
immunolog
defici
longterm
system
topic
antifung
therapi
despit
close
medic
attent
invas
case
fungal
rhinosinus
progress
fatal
outcom
becom
recurr
problem
chronic
invas
fungal
rhinosinus
divid
granulomat
nongranulomat
subtyp
basi
histopatholog
howev
clinic
distinct
term
prognosi
manag
subtyp
clear
chronic
invas
fungal
rhinosinus
specif
associ
aspergillu
speci
mucor
speci
alternaria
speci
curvularia
speci
bipolari
speci
candida
speci
sporothrix
schenckii
pseudallescheria
boydii
tradit
classif
fungal
rhinosinus
emphas
differenti
diseas
basi
presenc
absenc
tissu
invas
littl
emphasi
place
differenti
fungal
inflamm
induc
colon
versu
infect
littl
question
invas
form
fungal
rhinosinus
constitut
infect
issu
whether
noninvas
form
repres
infect
versu
inflamm
respons
colon
fungi
offer
confus
present
current
data
suggest
mucos
inflammatori
process
noninvas
fungal
colon
repres
noninfecti
process
allergi
fungi
unlik
invas
form
fungal
rhinosinus
potenti
colon
fungi
elicit
allerg
mucos
inflamm
absenc
invas
character
afr
abil
fungi
specif
protein
compon
fungi
elicit
igemedi
allerg
mucos
inflamm
well
document
moreov
sensit
individu
place
environ
high
fungal
exposur
symptom
airway
hyperrespons
increas
significantli
nonsensit
individu
similar
situat
virtual
studi
pathophysiolog
afr
base
premis
igemedi
allergi
one
fungi
underli
diseas
predomin
find
eosinophilpredomin
tissu
infiltr
akin
latephas
allerg
inflamm
way
afr
featur
quit
similar
allerg
bronchopulmonari
aspergillosi
b
classic
afr
cours
past
year
afr
emerg
clinic
distinct
subset
cr
afr
possess
characterist
clinic
radiograph
patholog
immunolog
featur
histori
physic
occasion
present
afr
might
dramat
give
rise
acut
visual
loss
gross
facial
dysmorphia
describ
complet
nasal
obstruct
often
present
afr
subtl
patient
typic
complain
gradual
nasal
airway
obstruct
product
semisolid
nasal
crust
inquiri
match
gross
descript
allerg
fungal
mucin
develop
nasal
airway
obstruct
might
gradual
patient
unawar
presenc
pain
uncommon
among
patient
afr
suggest
concomit
presenc
bacteri
rhinosinus
contrast
often
subtl
symptom
afr
physic
find
often
remark
rang
physic
find
examin
typic
broad
rang
nasal
airway
obstruct
result
intranas
inflamm
polyposi
gross
facial
disfigur
orbit
ocular
abnorm
radiolog
find
slow
accumul
allerg
fungal
mucin
provid
uniqu
rather
predict
characterist
diseas
allerg
fungal
mucin
sequest
within
involv
paranas
sinu
caviti
accumul
eventu
lead
increasingli
wellrecogn
radiograph
find
characterist
afr
tabl
vi
recent
studi
sinu
ct
scan
patient
afr
object
support
sever
previou
clinic
observ
afr
although
bilater
case
review
caus
asymmetr
involv
paranas
sinus
case
bone
eros
extens
diseas
adjac
anatom
area
encount
patient
like
occur
presenc
bilater
advanc
diseas
expans
remodel
thin
involv
sinu
wall
common
thought
due
expansil
natur
accumul
mucin
find
corrobor
nussenbaum
et
al
review
ct
scan
patient
treat
afr
singl
institut
also
found
deminer
bone
approxim
subject
heterogen
area
signal
intens
within
paranas
sinus
fill
allerg
fungal
mucin
frequent
identifi
ct
scan
fig
although
find
specif
afr
remain
rel
characterist
diseas
might
provid
preoper
inform
support
diagnosi
afr
current
evid
point
presenc
accumul
heavi
metal
eg
iron
manganes
calcium
salt
precipit
within
inspiss
allerg
fungal
mucin
like
caus
radiograph
find
desicc
sinu
content
might
also
contribut
hyperdens
area
seen
ct
scan
mri
also
provid
inform
use
preoper
identif
allerg
fungal
mucin
effect
pronounc
imag
result
prolong
magnet
field
relax
time
high
protein
low
water
concentr
allerg
fungal
mucin
coupl
high
water
content
within
surround
edemat
paranas
sinu
mucosa
give
rise
rather
specif
magnet
reson
characterist
combin
ct
mri
find
provid
radiograph
appear
highli
suggest
afr
immunolog
test
studi
man
holman
prospect
compar
patient
cultureposit
bipolari
speci
afr
control
subject
cr
group
evalu
rast
elisa
inhibit
bipolari
speciesspecif
ige
igg
antibodi
skin
test
bipolari
speci
antigen
patient
afr
posit
skin
test
reaction
bipolari
speci
antigen
well
posit
rast
elisa
inhibit
result
bipolari
speciesspecif
ige
igg
comparison
control
subject
neg
result
skin
serolog
test
sever
studi
also
demonstr
posit
correl
skin
test
vitro
rast
respons
fungal
nonfung
antigen
patient
afr
moreov
patient
afr
appear
demonstr
broad
sensit
number
fungal
nonfung
antigen
basi
studi
gener
agre
patient
afr
posit
evid
fungal
allergi
fungu
colon
allerg
mucin
major
case
case
show
correl
might
technic
problem
fungal
cultur
lack
skin
test
reagent
might
explain
discrep
sensit
numer
fungi
indic
mean
vitro
rast
vivo
skin
test
method
although
gener
singl
fungu
isol
mean
cultur
correspond
allerg
fungal
mucin
previous
thought
result
either
common
fungal
epitop
genet
predisposit
toward
fungal
allergi
afr
recent
work
chrzanowski
et
al
identifi
presenc
protein
allerg
mucin
obtain
patient
afr
might
repres
fungal
panantigen
total
ige
valu
also
gener
increas
patient
afr
often
iuml
propos
clinic
use
indic
afr
diseas
activ
case
fungusspecif
igg
precipitin
also
detect
analog
describ
allerg
bronchopulmonari
aspergillosi
product
allerg
mucin
consid
pathognomon
afr
grossli
allerg
mucin
thick
tenaci
highli
viscou
consist
color
vari
light
tan
brown
dark
green
mucin
rather
paranas
sinu
mucosa
provid
histolog
inform
necessari
make
diagnosi
afr
examin
mucosa
polyp
obtain
involv
paranas
sinus
reveal
find
chronic
inflamm
usual
abund
eosinophil
patholog
examin
tissu
done
establish
fungal
invas
present
histolog
appear
allerg
mucin
reveal
characterist
find
branch
noninvas
fungal
hypha
within
sheet
eosinophil
charcotleyden
crystal
hematoxylin
eosin
stain
accentu
mucin
cellular
compon
allerg
fungal
mucin
fail
stain
fungal
hypha
fungi
recogn
uniqu
abil
absorb
silver
basi
variou
silver
stain
grocott
gomori
methamin
silver
stain
stain
fungi
black
dark
brown
unfortun
silverbas
stain
high
specif
low
sensit
sensit
method
identif
fungi
recent
develop
make
use
fluoresceinlabel
chitinspecif
bind
protein
studi
compar
mucu
retriev
patient
cr
use
techniqu
allow
identif
fungal
element
specimen
wherea
fungi
detect
specimen
use
grocott
stain
use
techniqu
taylor
et
al
identifi
fungal
hypha
vast
major
sinu
mucu
sampl
obtain
patient
cr
even
though
patient
lack
classic
featur
afr
becom
one
major
tenet
hypothesi
associ
concept
eosinophil
fungal
rhinosinus
see
cultur
fungi
fungal
cultur
allerg
fungal
mucin
might
provid
support
evid
diagnosi
subsequ
treatment
afr
must
interpret
caution
import
realiz
diagnosi
afr
neither
establish
elimin
basi
result
cultur
variabl
yield
fungal
cultur
render
afr
presenc
neg
fungal
cultur
quit
possibl
convers
posit
fungal
cultur
fail
confirm
diagnosi
afr
might
mere
repres
presenc
saprophyt
fungal
growth
reason
histolog
appear
allerg
mucin
remain
reliabl
indic
afr
diagnost
criteria
constel
clinic
radiograph
immunolog
featur
help
defin
diseas
focu
number
diagnost
criteria
patient
afr
uniformli
demonstr
characterist
gross
product
eosinophil
mucin
contain
noninvas
fungal
hypha
nasal
polyposi
characterist
radiograph
find
immunocompet
allergi
fungi
take
account
current
literatur
diagnosi
afr
minim
depend
identifi
combin
histolog
evid
fungal
hypha
within
eosinophil
mucin
host
allergi
fungu
diagnosi
might
suspect
basi
physic
examin
radiograph
find
howev
case
diagnosi
establish
sinu
tissu
mucu
obtain
sinu
surgeri
review
time
surgeri
patient
might
persist
opacifi
sinu
caviti
eosinophil
mucu
plu
polypoid
tissu
might
found
account
opacif
patient
nearli
alway
type
allerg
sensit
fungal
antigen
distinct
featur
plu
distinct
complic
diseas
includ
boni
eros
facial
dysmorphia
afr
repres
distinct
subset
much
broader
group
patient
cr
c
nonigemedi
eosinophil
fungal
inflamm
eosinophil
fungal
rhinosinus
hypothesi
cr
propos
ponikau
et
al
suggest
colon
fungi
sinu
mucu
play
much
broader
role
pathogenesi
cr
use
ultrasensit
cultur
techniqu
consecut
patient
cr
demonstr
posit
fungal
cultur
nasal
lavag
examin
surgic
obtain
specimen
patient
also
reveal
eosinophil
fungal
hypha
sinu
mucu
nearli
patient
also
observ
group
healthi
control
subject
posit
fungal
cultur
nasal
lavag
convent
igemedi
allergi
fungi
consist
observ
patient
cr
propos
virtual
case
cr
associ
sensit
colon
fungi
suggest
term
allerg
fungal
rhinosinus
replac
eosinophil
fungal
rhinosinus
intrigu
issu
rais
studi
possibl
certain
fungi
could
elicit
eosinophil
inflamm
absenc
convent
ige
subject
cr
concept
support
vitro
studi
pbmc
patient
cr
found
produc
larg
quantiti
exposur
certain
fungal
antigen
contrast
pbmc
obtain
healthi
control
subject
fail
produc
respons
thu
patient
cr
show
evid
sensit
immun
activ
respons
colon
fungi
nasal
sinu
mucu
process
might
respons
product
cytokin
recruit
activ
eosinophil
cr
discuss
issu
see
section
controversi
cr
classifi
basi
propos
definit
eosinophil
fungal
rhinosinus
summari
statement
perenni
allerg
rhiniti
appear
predispos
factor
acut
bacteri
rhinosinus
cr
without
nasal
polyp
character
predominantli
neutrophil
inflamm
lesser
contribut
eosinophil
contrast
nasal
polyp
character
eosinophil
inflamm
eotaxin
shown
play
role
process
neither
total
ige
concentr
ecp
concentr
nasal
polyp
differ
atop
versu
nonatop
subject
indic
discord
system
allerg
phenotyp
local
inflammatori
mechan
lead
eosinophil
inflamm
np
role
propos
ige
specif
staphylococcalderiv
superantigen
pathogenesi
cr
associ
nasal
polyp
allerg
inflamm
contribut
allerg
respons
cr
long
controversi
nonetheless
evid
least
perenni
allerg
rhiniti
could
facilit
factor
acut
bacteri
rhinosinus
demonstr
prospect
sinu
ct
scan
studi
although
season
allerg
rhiniti
shown
risk
factor
orbit
complic
acut
rhinosinus
children
similar
evid
avail
acut
rhinosinus
adult
mous
model
allerg
inflamm
induc
mean
sensit
ovalbumin
also
demonstr
augment
inflammatori
respons
acut
bacteri
infect
furthermor
allerg
reactiv
poor
prognost
factor
surgeri
studi
studi
allerg
factor
cr
involv
studi
np
result
studi
unclear
slightli
less
half
patient
cr
np
associ
allergi
furthermor
season
allergen
exposur
increas
symptom
mediat
nasal
lavag
patient
np
ragwe
sensit
howev
substanti
discord
skin
prick
test
evid
local
ige
antibodi
level
polyp
homogen
earli
drakele
mclaughlin
report
find
ige
antibodi
np
differ
local
ige
level
allerg
nonallerg
subject
recent
studi
found
ige
np
specif
enterotoxin
aureu
act
superantigen
result
multiclon
stimul
b
lymphocyt
anoth
studi
report
skew
vb
phenotyp
lymphocyt
np
toward
respons
staphylococc
exotoxin
detect
tissu
repeatedli
demonstr
least
qualit
speak
neither
ige
level
ecp
concentr
np
differenti
atop
versu
nonatop
subject
indic
phenotyp
system
allergi
defin
skin
prick
test
posit
correl
local
featur
allerg
inflamm
np
full
explan
find
remain
elus
implic
local
inflammatori
mechan
might
import
np
pathogenesi
furthermor
posit
skin
test
respons
patient
cr
interpret
allerg
case
cr
one
except
rule
afr
system
allerg
respons
fungi
colon
sinu
mucu
demonstr
vast
major
case
see
section
controversi
cr
classifi
basi
propos
definit
eosinophil
fungal
rhinosinus
signific
bodi
work
done
character
tcell
cytokin
profil
np
review
studi
subclassifi
np
allerg
nonallerg
subtyp
basi
result
allergi
skin
test
profil
tcell
cytokin
found
np
tissu
clear
distinct
import
underli
diseas
pathogenesi
allerg
nonallerg
patient
np
manifest
promin
eosinophil
tissu
infiltr
see
section
factor
involv
nasal
polyposi
studi
patient
cr
without
polyposi
limit
also
shown
differ
subject
without
allerg
sensit
princip
differ
involv
greater
degre
neutrophil
inflamm
lesser
degre
eosinophil
inflamm
nonallerg
patient
howev
eosinophil
infiltr
seen
degre
allerg
nonallerg
patient
analog
find
np
also
similar
result
patient
np
tcell
cytokin
profil
allerg
nonallerg
subject
cr
show
differ
precis
describ
subject
np
name
full
cadr
h
cytokin
found
allerg
subject
mix
h
h
profil
found
nonallerg
subject
howev
degre
tissu
infiltr
eosinophil
substanti
differ
allerg
nonallerg
subject
rais
question
relev
system
allerg
phenotyp
underli
pathogenesi
inflammatori
featur
cr
without
np
rang
mediat
cytokin
shown
increas
comparison
level
seen
control
tissu
mostli
inferior
turbin
includ
tnfa
gmcsf
myeloperoxidas
ecp
cr
character
predominantli
neutrophil
inflamm
lesser
contribut
eosinophil
interestingli
vascular
cell
adhes
molecul
adhes
molecul
involv
select
eosinophil
recruit
key
cytokin
eosinophil
surviv
activ
shown
increas
cytokin
mediat
profil
resembl
much
profil
found
acut
viral
rhinosinus
except
small
although
signific
increas
ecp
find
therefor
suggest
underli
patholog
process
might
involv
unresolv
inflamm
infect
respons
chronic
infect
profil
distinct
pattern
np
comparison
mani
studi
done
describ
inflamm
np
see
section
factor
involv
nasal
polyposi
hallmark
inflammatori
featur
presenc
abund
eosinophil
varieti
mechan
propos
account
presenc
eosinophil
np
discuss
previous
mention
characterist
featur
np
local
product
ige
increas
igeproduc
plasma
cell
compar
seen
control
subject
analysi
specif
ige
reveal
multiclon
ige
respons
np
tissu
ige
antibodi
aureu
enterotoxin
sae
patient
subject
np
asthma
total
specif
ige
level
polyp
homogen
partial
reflect
serum
patient
classic
sae
especi
toxic
shock
syndrom
toxin
staphylococcu
protein
excel
candid
induc
multiclon
ige
synthesi
increas
releas
well
express
ligand
cell
b
cell
staphylococcu
protein
furthermor
interact
famili
immunoglobulin
heavi
chain
variabl
gene
product
thu
preferenti
plasma
cell
present
immunoglobulin
surfac
lead
bia
fact
folliclelik
aggreg
found
nasal
polyp
express
b
cell
cell
ige
plasma
cell
larg
lack
dendrit
antigenpres
cell
support
concept
superantigen
stimul
sae
furthermor
stimul
cell
bind
variabl
b
chain
tcell
receptor
induc
cytokin
product
directli
activ
eosinophil
prolong
surviv
also
might
directli
activ
epitheli
cell
releas
chemokin
sae
furthermor
activ
antigenpres
cell
increas
antigen
uptak
fact
compar
saeig
np
saeig
np
number
ige
cell
eosinophil
significantli
increas
sever
inflamm
also
reflect
significantli
increas
level
ecp
total
ige
np
conclus
sae
abl
induc
sever
eosinophil
inflamm
well
synthesi
multiclon
ige
respons
high
total
ige
concentr
tissu
would
suggest
sae
least
modifi
diseas
np
interestingli
similar
find
recent
report
asthma
known
occur
concurr
nasal
polyposiss
ige
antibodi
format
sae
rare
seen
cr
absenc
np
summari
statement
overact
underact
autonom
nerv
pathway
abnorm
leukotrien
product
respons
nocicept
dysfunct
local
irrit
caus
gastroesophag
reflux
demonstr
select
subset
patient
rhinosinus
like
predispos
pathogenesi
cr
defect
mucociliari
clearanc
antibodi
defici
syndrom
might
predispos
rhinosinus
aspirinassoci
respiratori
diseas
predispos
rhinosinus
rhinosinus
classifi
result
either
inflammatori
noninflammatori
caus
tabl
vii
within
classif
caus
divid
follow
section
review
variou
causal
factor
rhinosinus
emphasi
noninfecti
nonimmunolog
caus
b
neutrophil
rhiniti
neutrophil
group
includ
acut
bacteri
sinus
cystic
fibrosi
chronic
bacteri
infect
complic
immunodefici
foreign
bodi
nasal
polyp
neutrophilia
children
highli
suggest
cystic
fibrosi
c
mix
inflammatori
pattern
complex
mix
yet
poorli
defin
nasal
mucos
cell
popul
present
viral
infect
autoimmun
diseas
idiopath
diseas
leukocyt
attract
nasal
sinu
mucosa
vari
chronolog
specif
viru
caus
acut
common
cold
syndrom
rhinoviru
parainfluenza
viru
adenoviru
coronaviru
other
influenza
might
caus
epitheli
destruct
potenti
steril
nonbacteri
rhinosinus
adenoid
time
cours
leukocyt
invas
differ
specif
leukocyt
popul
necessari
synchron
day
initi
infect
follow
time
cours
achiev
longitudin
studi
group
inocul
viru
crosssect
studi
date
onset
infect
document
precis
autoimmun
vasculit
complex
syndrom
includ
group
virtu
poorli
defin
mix
cellular
popul
lymphocyt
infiltr
cell
deriv
might
present
might
also
chang
stage
durat
ill
exampl
would
sarcoidosi
predomin
h
lymphocyt
macrophag
noncas
granuloma
epitheli
dysplasia
epitheli
chang
occur
cr
progress
mild
sever
epithelium
show
inexor
trend
normal
ciliat
goblet
cell
predomin
microvil
cell
predomin
ultim
squamou
epithelium
breach
basement
membran
surfac
erythrocyt
indic
bleed
epitheli
progress
roughli
parallel
ct
scan
sever
exposur
organ
toxin
fine
particul
materi
oxid
miner
eg
iron
materi
lead
epitheli
differenti
ciliat
squamou
metaplasia
without
leukocytosi
olfactori
mucosa
might
particularli
suscept
exampl
type
respons
exposur
complex
particul
toxin
caus
earli
transient
neutrophil
inflamm
clear
rapidli
exposur
end
type
chang
examin
rodent
screen
toxicolog
studi
much
fewer
data
human
exposur
situat
noninflammatori
chang
second
larg
group
set
noninflammatori
syndrom
show
chang
normal
leukocyt
infiltr
trigemin
dysfunct
mani
disord
involv
affer
trigemin
effer
autonom
nerv
often
dismiss
function
disord
nasal
complaint
without
physic
find
lump
togeth
vasomotor
rhiniti
idiopath
rhiniti
misnom
justic
patient
complaint
perenni
noninfecti
nonallerg
rhiniti
altern
term
clear
vascular
motor
inflammatori
cellular
pattern
inquiri
key
histor
issu
classifi
direct
therapi
symptomat
frustrat
patient
individu
appear
increas
affer
trigemin
nerv
sensit
inhal
irrit
disord
axon
respons
mechan
potenti
alter
dorsal
horn
process
nocicept
input
contribut
increas
percept
mucos
viscer
stimuli
henc
greater
complaint
symptom
altern
term
irrit
rhiniti
describ
syndrom
accur
patient
irrit
rhiniti
typic
complain
nasal
congest
rhinorrhea
respons
weather
temperatur
humid
chang
irrit
tobacco
smoke
gasolin
fume
perfum
clean
solut
beer
wine
import
function
type
c
nocicept
neuron
role
immedi
neurogen
respons
noxiou
stimuli
new
inform
natur
nocicept
sensor
capsaicinsensit
ion
channel
receptor
recent
renam
transient
receptor
potenti
vanilloid
subfamili
protein
offer
new
understand
molecular
mechan
underli
respons
irrit
gase
fine
particul
materi
cigarett
smoke
compon
osmolar
temperatur
chang
b
cholinerg
rhiniti
affer
stimuli
recruit
overact
parasympathet
cholinerg
reflex
mediat
cholinerg
muscarin
receptor
glandular
secret
mucu
hypersecret
might
confound
observ
mucopurul
discharg
therefor
suggest
rhinosinus
present
effect
anticholinerg
agent
suggest
parasympathet
cholinerg
outflow
major
factor
contribut
chronic
longlast
irritantinduc
eg
cold
dri
air
skier
nasal
discharg
nonallerg
rhiniti
acut
stimul
nocicept
nerv
eg
eat
capsaicinladen
food
stimul
vanilloid
receptor
bear
type
c
trigemin
neuron
also
recruit
overwhelm
lacrim
nasal
salivari
glandular
discharg
excess
term
cholinerg
rhiniti
anticholinerg
agent
effect
block
cn
trigeminalfaci
vidian
parasympathet
nervemedi
reflex
c
sympathet
dysfunct
impair
sympathet
outflow
lead
default
dilat
venou
sinusoid
thicken
mucosa
reduc
crosssect
area
airflow
therefor
lead
obstruct
nasal
airflow
horner
syndrom
exampl
hormon
structur
neoplast
disord
also
lead
symptom
includ
refer
pain
suggest
rhinosinus
hormon
pregnanc
notori
caus
nasal
obstruct
symptom
problemat
patient
congest
clear
deliveri
placenta
hypothyroid
lead
sympathet
dysfunct
ineffect
noradrenerg
effect
absenc
venou
sinusoid
vasoconstrict
result
default
blood
pool
thicken
nasal
mucosa
drug
block
vasoconstrictor
function
central
peripher
act
antihypertens
agent
also
lead
mucos
thicken
nasal
obstruct
airflow
import
nocicept
neural
mechan
hyperalgesia
rhinosinus
demonstr
studi
tender
sinu
region
although
pain
patient
subject
complaint
tender
palpat
function
spinal
cord
pain
process
hyperalgesia
subject
acut
rhinosinus
cr
significantli
lower
pain
threshold
sinu
region
compar
healthi
control
subject
fig
studi
valid
sign
sinu
tender
diagnosi
rhinosinus
differ
sensit
usual
nonpain
stimuli
allodynia
studi
rhinosinus
patient
allerg
rhiniti
intermedi
tender
threshold
significantli
differ
control
subject
nerv
growth
factor
potenti
neurotrophin
releas
mast
cell
lymphocyt
activ
cell
allerg
rhiniti
might
induc
hyperalges
sensori
chang
howev
challeng
demonstr
alter
allerg
rhiniti
sever
symptomat
untreat
patient
allerg
rhiniti
must
challeng
highli
pain
dose
capsaicin
identifi
respons
cr
might
repres
better
model
investig
neurogen
chang
larger
magnitud
hyperalgesia
studi
patient
rhinosinus
begin
import
find
studi
subject
chronic
fatigu
syndrom
particularli
complain
cr
significantli
lower
sinu
pain
threshold
control
group
well
acut
rhinosinus
cr
group
import
mani
subject
normal
sinu
ct
scan
carri
diagnosi
nonallerg
irrit
rhiniti
inclus
rhinosinus
studi
might
confound
studi
outcom
might
respond
rhinosinus
therapi
identifi
mean
questionnair
system
tender
aspirinexacerb
respiratori
diseas
adultonset
disord
defin
triad
asthma
np
rhinosinus
diseas
progress
irrespect
whether
individu
ingest
cyclooxygenas
inhibitor
aspirin
nonsteroid
antiinflammatori
drug
ingest
trigger
sever
upper
lower
respiratori
tract
reaction
disord
diagnos
mean
oral
aspirin
challeng
outsid
unit
state
mean
inhal
lysineaspirin
would
use
identifi
pure
nasal
reactor
nasal
inhal
lysineaspirin
also
studi
although
highli
sensit
difficult
patient
endur
withdraw
specif
oral
challeng
antihistamin
high
dose
oral
steroid
avoid
challeng
prevent
nasocular
reaction
aspirin
howev
nasal
steroid
leukotrien
modifi
zileuton
montelu
kast
continu
appear
capabl
inhibit
nasocular
reaction
leukotrien
modifi
block
upper
airway
respons
aspirinsensit
patient
zileuton
inhibit
enzym
dose
montelukast
appear
signific
factor
gastroesophag
reflux
diseas
gastroesophag
reflux
diseas
gerd
typic
produc
reflux
stomach
acid
lower
esophagu
especi
supin
acid
also
reflux
oropharynx
nose
sinus
produc
upper
airway
symptom
includ
rhinosinus
symptom
includ
hoars
cough
postnas
drip
nasal
congest
drainag
condit
also
refer
supraesophag
reflux
diseas
serd
although
rhinosinus
symptom
occur
patient
typic
gerd
studi
shown
patient
ear
nose
throat
symptom
typic
gerd
pathophysiolog
condit
believ
direct
contact
upper
airway
gastric
content
includ
acid
pepsin
duoden
content
includ
bile
acid
pancreat
enzym
like
trypsin
vagalmedi
reflex
also
implic
addit
possibl
mechan
includ
defect
upper
esophag
sphincter
pressur
esophag
dysmotil
poor
acid
clearanc
diagnosi
supraesophag
reflux
somewhat
difficult
test
commonli
use
diagnos
gerd
less
effect
serd
includ
upper
gastrointestin
examin
endoscopi
bernstein
acid
perfus
test
manometri
reflux
scintiscan
effect
test
make
diagnosi
serd
includ
ph
monitor
gold
standard
empir
therapeut
trial
empir
therapeut
trial
would
use
research
studi
unless
one
first
placebocontrol
empir
treatment
trial
determin
elig
propos
research
probe
place
proxim
esophagu
cm
upper
esophag
sphincter
pharynx
accomplish
high
specif
howev
sensit
vari
studi
address
role
acid
suppress
treat
cr
studi
open
treatment
protocol
children
difficulttomanag
cr
dual
ph
probe
monitor
perform
enrol
subject
one
trial
serd
case
patient
note
improv
studi
contribut
factor
rhinosinus
defect
mucociliari
clearanc
antibodi
defici
syndrom
great
deal
written
regard
role
defect
mucociliari
clearanc
humor
immun
defici
contribut
factor
rhinosinus
extens
review
recent
articl
therefor
discuss
length
confer
sinu
pressur
threshold
mean
ci
decreas
healthi
control
nonchron
fatigu
syndromeno
rhinosinus
chronic
fatigu
syndromecr
group
signific
differ
found
nonchron
fatigu
syndromeno
rhinosinus
p
p
p
p
chronic
fatigu
syndromecr
p
p
chronic
fatigu
syndromeno
rhinosinus
p
p
sinu
threshold
significantli
reduc
subject
chronic
fatigu
syndrom
subject
without
chronic
fatigu
syndrom
acut
rhinosinus
cr
compar
nonchron
fatigu
syndromeno
rhinosinus
control
group
cf
chronic
fatigu
syndrom
sinus
rhinosinus
crswnp
ie
differ
pattern
cellular
content
gross
histolog
chang
within
tissu
especi
regard
fibrosi
edema
mucos
line
crssnp
character
basement
membran
thicken
goblet
cell
hyperplasia
limit
subepitheli
edema
promin
fibrosi
mononuclear
cell
infiltr
contrast
crswnp
reveal
frequent
epitheli
damag
thicken
basement
membran
mostli
edemat
sometim
fibrot
stromal
tissu
reduc
number
vessel
gland
virtual
neuron
structur
cr
known
manifest
polypoid
nonpolypoid
form
recent
studi
examin
histolog
middl
turbin
tissu
subject
polypoid
versu
nonpolypoid
diseas
support
distinct
studi
malekzadeh
et
al
preoper
sinu
ct
scan
histolog
specimen
middl
turbin
obtain
sinu
surgeri
examin
retrospect
patient
compar
control
patient
underw
cosmet
spenopalatin
surgeri
ct
scan
sever
classifi
accord
may
classif
tissu
section
stain
mucu
cell
gland
alcian
blue
goblet
cell
often
present
epitheli
metaplasia
area
tissu
section
epitheli
basement
membran
assess
mean
digit
imag
analysi
percentag
area
stain
blue
determin
fig
normal
may
class
mild
may
class
sinus
show
approxim
mucou
cell
nasal
airway
mucosa
similar
percentag
found
class
ii
howev
subject
could
divid
rel
normal
histolog
show
cobbleston
mucosa
small
polyp
surgeri
accompani
suggest
increas
mucos
edema
shown
biedlingmai
trifilli
subject
goblet
cell
metaplasia
decreas
ciliat
cell
major
differ
mucos
histolog
seen
class
iii
one
popul
subject
show
thicken
mucosa
visual
inspect
glandular
mucou
cell
hyperplasia
mucosa
stain
alcian
blue
indic
mechan
activ
caus
glandular
hyperplasia
potenti
mechan
could
similar
suggest
chronic
bronchiti
murin
model
show
goblet
cell
hyperplasia
popul
patient
visual
evid
polyposi
histolog
patient
polyp
show
decreas
percentag
alcian
blue
area
diseas
sever
worsen
class
ii
class
iv
pansinus
ultim
polypoid
degener
total
obliter
normal
mucos
histolog
region
polyp
root
patient
polypoid
diseas
also
like
manifest
chang
pansinus
sinu
ct
result
strongli
suggest
distinct
molecular
mechan
underli
polypoid
glandular
hypertrophi
subset
cr
distinct
histolog
pattern
independ
support
sever
studi
similar
dichotomi
seen
clinic
radiolog
treatment
respons
eichel
patient
polyposi
detect
mean
observ
ct
scan
resist
medic
therapi
often
need
combin
surgic
longterm
medic
intervent
polypoid
diseas
gener
recurr
despit
medic
followup
treatment
nonpolypoid
sinus
group
gener
respond
favor
medic
therapi
case
total
resolut
symptom
previous
state
histolog
epithelium
also
note
chang
radiograph
diseas
sever
assess
may
classif
normal
nasal
epithelium
ciliat
pseudostratifi
class
ii
cell
replac
goblet
cell
class
iii
microvil
cell
predomin
popul
squamou
metaplasia
present
class
iv
erythrocyt
patch
denud
epithelium
also
seen
suggest
mechan
invas
microb
usual
protect
line
essenc
nasal
sinu
mucosa
differenti
skinlik
squamou
epithelium
epitheli
chang
offer
novel
ecolog
nich
microbi
colon
invas
might
explain
differ
bacteri
organ
cultur
acut
rhinosinus
presum
ciliat
epithelium
versu
cr
microvil
squamou
epithelium
group
epitheli
chang
amen
treatment
might
improv
intens
therapi
surgeri
polypoid
nonpolypoid
cr
crswnp
vs
crssnp
also
gener
show
differ
pattern
cellular
content
gross
histolog
chang
within
tissu
especi
edema
fibrosi
format
sinu
fluid
patient
crssnp
undergo
surgeri
inflammatori
cell
predominantli
neutrophil
observ
acut
sinus
low
percentag
eosinophil
mast
cell
basophil
might
also
found
recent
studi
evalu
percentag
eosinophil
inflammatori
cell
count
per
vision
field
patient
untreat
chronic
sinus
without
np
less
eosinophil
overal
mean
wherea
specimen
untreat
patient
np
sampl
show
eosinophil
overal
mean
among
inflammatori
cell
activ
eosinophil
promin
characterist
featur
patient
crswnp
eosinophil
local
around
vessel
gland
directli
beneath
mucos
epithelium
mucos
line
patient
crssnp
character
basement
membran
thicken
goblet
cell
hyperplasia
limit
subepitheli
edema
promin
fibrosi
mononuclear
cell
infiltr
histomorpholog
character
np
tissu
crswnp
reveal
frequent
epitheli
damag
thicken
basement
membran
mostli
edemat
sometim
fibrot
stromal
tissu
reduc
number
vessel
gland
virtual
neuron
structur
stroma
matur
polyp
mainli
character
edemat
natur
consist
support
fibroblast
infiltr
inflammatori
cell
local
around
empti
pseudocyst
format
small
polyp
larger
mm
grow
normallook
mucosa
middl
turbin
patient
bilater
polyposi
earli
process
polyp
growth
studi
numer
subepitheli
eosinophil
present
lumin
compart
earlystag
polyp
form
cap
central
pseudocyst
area
fibronectin
deposit
notic
around
eosinophil
lumin
compart
earlystag
polyp
form
networklik
structur
polyp
center
within
pseudocyst
presenc
myofibroblast
limit
central
pseudocyst
area
interestingli
albumin
probabl
plasma
protein
deposit
within
pseudocyst
adjac
eosinophil
infiltr
observ
suggest
central
deposit
plasma
protein
regul
subepitheli
eosinophil
inflamm
pathogen
principl
polyp
format
growth
extravas
plasma
reason
distanc
bind
forc
extracellular
matrix
damag
abnorm
might
find
way
airway
surfac
addit
discuss
signific
polypoid
versu
nonpolypoid
cr
see
section
controversi
p
distinguish
infecti
noninfectiousinflammatori
subtyp
cr
histolog
ground
unfortun
although
evid
present
confer
would
suggest
might
infecti
noninfectiousinflammatori
subtyp
cr
gener
lack
inform
support
refut
histolog
ground
import
area
need
studi
know
patholog
np
come
studi
inflammatori
np
would
best
fit
descript
edemat
eosinophil
type
np
might
includ
np
neutrophil
mix
inflamm
cell
initi
studi
found
heterogen
appear
np
despit
fact
subject
symptom
cr
minimum
week
associ
histori
bilater
np
mucos
thicken
sinu
ct
scan
likewis
studi
report
heterogen
histolog
appear
np
patholog
signific
heterogen
unclear
kept
mind
interpret
data
np
studi
characterist
symptom
crswnp
includ
nasal
congest
facial
painpressureful
postnas
drainag
hyposmiaanosmia
facial
pain
fever
uncommon
characterist
clinic
appear
bilater
np
fact
presenc
unilater
np
prompt
consider
condit
afr
invert
papilloma
antral
choanal
nasal
polyp
unusu
polypoid
lesion
nasal
tumor
radiograph
sinu
ct
scan
sinu
mucos
thicken
usual
present
multipl
sinu
area
bilater
along
bilater
np
assess
mean
prick
intraderm
skin
test
approxim
patient
nonallerg
overal
patient
asthma
patient
aspirin
intoler
noninfecti
cr
major
case
cr
promin
polypoid
tissu
present
result
bacteri
cultur
neg
even
sensit
pcr
techniqu
fail
demonstr
bacteri
infect
case
consist
studi
antral
punctur
maxillari
sinu
perform
subject
crswnp
posit
cultur
found
patient
lack
evid
bacteri
infect
lack
sinu
painpressur
fever
experienc
patient
typic
appear
np
tissu
show
pattern
chronic
inflamm
predomin
eosinophil
rel
pauciti
neutrophil
crswnp
refer
noninfecti
cr
earli
featur
np
one
studi
attempt
describ
earli
featur
edemat
eosinophilictyp
np
studi
subject
evid
develop
polypoid
lesion
middl
turbin
ever
polyp
earli
featur
lesion
presenc
eosinophil
form
subepitheli
cap
pseudocyst
area
fill
albumin
later
featur
larg
pseudocyst
area
contain
albumin
surround
subepitheli
eosinophil
histolog
np
show
chronic
inflammatori
infiltr
increas
number
eosinophil
influx
eosinophilbasophil
bone
marrow
progenitor
cell
special
stain
typic
reveal
mild
increas
number
mast
cell
evid
mast
cell
degranul
plasma
cell
increas
comparison
normal
nasal
mucosa
mean
immunohistochem
stain
number
macrophag
neutrophil
lymphocyt
normal
howev
one
studi
cell
isol
digest
nasal
polyp
tissu
lymphocyt
predomin
lymphocyt
studi
report
normal
mildli
increas
number
lymphocyt
howev
increas
activ
cell
dual
immunostain
reveal
increas
number
lymphocyt
allerg
nonallerg
patient
also
increas
express
eselectin
pselectin
np
endothelium
increas
local
product
chemokin
eg
rant
eotaxin
especi
epithelium
also
submucos
fibroblast
numer
cytokin
chemokin
overexpress
np
respect
lymphocyt
profil
mix
h
h
cytokin
profil
increas
gmcsf
level
also
present
level
rel
similar
allerg
nonallerg
subject
also
increas
express
proinflammatori
cytokin
addit
cytokin
chemokin
mediat
histamin
also
markedli
increas
nasal
polyp
exceed
level
ngml
increas
level
tryptas
histamin
ecp
report
polyp
tissu
nasal
lavag
fluid
patient
np
compar
seen
without
np
addit
increas
level
iga
ige
igg
igm
polyp
fluid
tissu
report
also
evid
remodel
np
includ
increas
glandular
prolifer
increas
number
blood
vessel
increas
asma
myofibroblast
deposit
collagen
type
iii
v
sever
profibrot
cytokin
found
increas
np
includ
gmcsf
tgfb
plateletderiv
growth
factor
fibroblast
growth
factor
vascular
endotheli
growth
factor
epiderm
growth
factor
insulinlik
growth
factor
signific
amount
constitut
matrix
metalloproteinas
mmp
mrna
report
np
fibroblast
express
found
upregul
cytokin
mast
cell
known
play
key
role
igemedi
diseas
also
involv
nonigemedi
inflammatori
diseas
mast
cell
detect
epithelium
stroma
np
also
seen
nasal
mucosa
patient
allerg
rhiniti
contrast
allerg
nasal
mucosa
major
degranul
mast
cell
local
deep
stroma
suggest
mast
cell
np
like
activ
inhal
allergen
mast
cell
express
varieti
cytokin
gmcsf
tnfb
mast
cell
mediat
histamin
tryptas
capabl
upregul
releas
rant
gmcsf
stem
cell
factor
thymu
activationregul
chemokin
np
epitheli
cell
fibroblast
indic
viciou
cycl
perpetu
eosinophil
inflamm
fact
recent
observ
increas
level
tryptas
ecp
recurr
np
compar
level
found
fresh
untreat
np
also
good
correl
detect
level
ecp
tryptas
find
support
observ
di
lorenzo
et
al
level
tryptas
ecp
nasal
lavag
sampl
patient
np
correl
symptom
score
furthermor
histamin
mast
cell
upregul
product
fibronectin
chymas
tryptas
upregul
product
mast
cell
stimul
varieti
way
convent
allergi
eg
bacteria
viru
fungi
complement
autoantibodi
mast
cell
might
contribut
induct
eosinophil
inflamm
releas
variou
inflammatori
mediat
indirectli
activ
structur
cell
thu
contribut
format
progress
np
j
allergi
clin
immunol
volum
number
sever
patholog
process
act
concert
promot
accumul
eosinophil
np
includ
infiltr
np
eosinophilbasophil
progenitor
cell
increas
local
surviv
eosinophil
np
tissu
depend
local
evid
local
product
gmcsf
upregul
endotheli
pselectin
product
cc
chemokin
epithelium
np
fibroblast
local
product
might
contribut
adhes
molecul
express
enhanc
action
eotaxin
airway
tissu
increas
local
product
allerg
nonallerg
subject
crswnp
major
cell
np
lymphocyt
remaind
primarili
eosinophil
mast
cell
least
suggest
immun
specif
activ
process
might
involv
diseas
process
princip
survivalpromot
cytokin
np
local
produc
might
also
serv
system
stimulu
bone
marrow
eosinophilipoiesi
patient
gmcsf
abundantli
produc
crswnp
correl
number
eosinophil
present
contribut
sustain
activ
surviv
eosinophil
np
much
local
product
gmcsf
np
probabl
result
autoactiv
eosinophil
proinflammatori
cytokin
tnfa
also
highli
overexpress
promot
np
inflamm
induct
endotheli
adhes
molecul
includ
pselectin
sever
investig
found
increas
express
molecul
np
sever
chemokin
overproduc
np
includ
cxc
chemokin
cc
chemokin
rant
eotaxin
might
imprecis
state
dysregul
cr
rather
product
epitheli
cell
might
well
part
innat
immun
respons
sinu
infect
howev
evid
dysregul
epitheli
cc
chemokin
product
includ
rant
eotaxin
np
epithelium
chemokin
might
import
promot
local
chemotaxi
eosinophil
increas
np
allerg
nonallerg
subject
function
mediat
receptor
chain
distinct
produc
given
lack
evid
overexpress
nonallerg
patient
might
play
import
role
diseas
pathogenesi
accord
current
understand
eotaxin
major
factor
eosinophil
inflamm
correl
significantli
ecp
recent
regul
receptor
exist
solubl
transmembran
isoform
investig
np
probabl
antagonist
solubl
isoform
upregul
signaltransduc
transmembran
isoform
downregul
especi
associ
asthma
sever
group
investig
cytokin
profil
lymphocyt
np
found
mix
phenotyp
h
h
cytokin
evid
local
product
ifng
cytokin
profil
somewhat
differ
allerg
nonallerg
subject
characterist
h
cytokin
profil
seen
subject
crswnp
associ
allergi
wherea
mix
h
h
cytokin
profil
characterist
nonallerg
subject
howev
allerg
nonallerg
subject
increas
product
extent
tissu
eosinophil
infiltr
indistinguish
group
similar
differ
pattern
cytokin
express
found
allerg
versu
nonallerg
subject
crssnp
local
product
lymphocyt
like
great
import
promot
surviv
tissu
eosinophil
np
basi
patholog
featur
crswnp
limit
number
investig
possibl
consid
process
might
contribut
inflammatori
process
latephas
allerg
inflamm
respons
airborn
allergen
allerg
subject
crswnp
b
tcell
activ
product
ifng
respons
fungal
antigen
hypha
sinu
mucu
c
tcell
activ
cytokin
product
local
ige
product
respons
bacteri
superantigen
dysregul
sinu
epithelium
overproduct
chemokin
rant
allerg
subject
crswnp
presenc
complet
h
profil
cytokin
suggest
latephas
allerg
inflamm
might
contribut
diseas
howev
basi
studi
adkin
et
al
doubt
airborn
allergen
penetr
sinu
caviti
leav
open
question
latephas
inflammatori
process
driven
sinus
answer
might
lie
system
crosstalk
allerg
inflamm
ie
abil
allergeninduc
inflamm
one
site
induc
similar
respons
remot
site
type
interact
demonstr
nose
lung
preliminari
studi
suggest
similar
interact
might
occur
nose
sinus
increas
level
ige
receptor
fceri
express
detect
np
atop
subject
function
relev
could
caus
increas
igedepend
histamin
releas
np
mast
cell
patient
level
specif
ige
found
higher
np
tissu
compar
found
serum
patient
indic
local
ige
synthesi
crswnp
preliminari
evid
suggest
peripher
blood
lymphocyt
patient
cr
prolifer
produc
ifng
respons
fungal
antigen
particularli
demataci
fungi
alternaria
candida
speci
see
section
nonigemedi
eosinophil
fungal
inflamm
cytokin
profil
match
found
np
tissu
lymphocyt
isol
np
therefor
support
concept
might
import
immun
respons
pattern
crswnp
howev
respons
profil
specif
fungi
also
seen
respons
superantigen
c
bacteri
infect
might
also
associ
ige
sensit
increas
bacteriaspecif
ige
shift
h
cytokin
profil
fact
bachert
et
al
detect
specif
ige
staphylococc
enterotoxin
b
np
found
level
ige
correl
eosinophil
infiltr
demonstr
multiclon
ige
includ
specif
ige
staphylococc
enterotoxin
staphylococc
enterotoxin
b
bilater
eosinophil
np
similar
level
superantigenspecif
ige
found
atop
nonatop
subject
suggest
potenti
common
inflammatori
respons
group
subject
also
asthma
ige
upregul
mast
cell
fceri
express
mast
cell
activ
observ
suggest
role
mast
cell
regul
chronic
eosinophil
inflamm
holtzman
et
al
describ
mechan
tcell
transmigr
epithelium
involv
cc
chemokin
rant
propos
epithelium
asthma
constitut
dysregul
ie
express
produc
rant
independ
exogen
stimuli
dysregul
appear
associ
increas
nuclear
factor
kb
activ
airway
epithelium
function
consequ
action
facilit
tlymphocyt
migrat
epitheli
compart
show
dysregul
involv
overact
transcript
factor
signal
transduc
activ
transcript
requir
presenc
ifng
given
mani
similar
inflammatori
featur
asthma
crswnp
possibl
similar
type
dysregul
present
crswnp
cr
subclassifi
import
issu
discuss
confer
whether
current
evid
suffici
subclassifi
cr
distinct
subcategori
lead
consider
discuss
debat
controversi
issu
summar
consensu
opinion
express
confer
summar
mani
publish
studi
cr
made
distinct
cr
cr
concomit
np
studi
regard
patient
bilater
np
form
distinct
subset
patient
cr
confer
discuss
center
whether
cr
formal
subclassifi
crssnp
crswnp
purpos
advanc
knowledg
underli
patholog
process
involv
mean
sharpen
focu
therapeut
trial
consensu
opinion
favor
subclassif
evid
discuss
previous
section
histolog
factor
cr
allerg
immunolog
factor
rhinosinus
support
concept
differ
pathogen
process
involv
crssnp
crswnp
addit
differ
inflammatori
cellular
infiltr
cytokin
mediat
profil
immun
respons
sae
differ
also
describ
remodel
process
crssnp
versu
crswnp
express
protein
rna
level
significantli
higher
crssnp
versu
crswnp
link
fibrot
crossanatomi
contrast
edema
pseudocyst
format
character
crswnp
area
fibrosi
furthermor
imbal
mmp
upregul
crswnp
found
wherea
crssnp
natur
antagonist
increas
result
enhanc
crswnp
wherea
crssnp
activ
inhibit
differ
metalloproteinas
level
might
account
edema
format
albumin
retent
crswnp
versu
fibrosi
crssnp
publish
studi
requir
patient
bilater
np
visibl
middl
meatu
satisfi
criteria
np
basi
histolog
assess
presenc
eosinophil
gener
natur
inflammatori
respons
similar
np
maxillari
polypoid
mucosa
patient
previou
surgeri
evid
polyposi
might
remov
reason
classifi
patient
postop
crswnp
categori
least
period
time
might
case
instanc
drug
studi
put
action
drug
might
prevent
recurr
np
earliest
stage
polyposi
like
crswnp
could
distinguish
crssnp
focal
polypoid
mucos
chang
middl
turbin
suggest
earli
featur
crswnp
howev
prospect
studi
test
hypothesi
done
manifest
polypoid
tissu
nasal
turbin
sinu
caviti
unclear
signific
satisfi
criteria
np
thu
purpos
classif
patient
cr
presenc
np
middl
meatu
either
past
present
defin
subset
patient
crswnp
although
pauciti
studi
directli
compar
clinic
featur
patient
crssnp
crswnp
clinic
differ
subgroup
describ
term
gener
tendenc
symptom
facial
painpressureful
gener
less
common
reduc
sens
smell
hyposmia
anosmia
gener
common
crswnp
howev
larg
overlap
symptom
form
cr
reason
gener
symptom
criteria
propos
defin
cr
case
see
section
rhinosinus
consensu
definit
clinic
trial
guidelin
patient
np
like
manifest
blood
eosinophilia
asthma
aspirin
sensit
patient
crssnp
appear
like
manifest
sign
bacteri
infect
report
better
respons
medic
treatment
develop
crssnp
long
view
result
abnorm
ventil
drainag
sinus
nasal
caviti
howev
increas
appreci
complex
disord
acknowledg
persist
inflamm
usual
present
crssnp
frequent
includ
degre
tissu
eosinophil
infiltr
glandular
dysfunct
might
also
play
import
role
pathogenesi
crssnp
suggest
malekzadeh
et
al
phenotyp
cr
also
appear
affect
prognosi
surgic
medic
intervent
use
rhinoscop
grade
system
kennedi
et
al
found
patient
advanc
mucos
polypoid
chang
preoper
much
higher
rate
recurr
diseas
relaps
endoscop
surgeri
similarli
subramanian
et
al
found
patient
past
histori
current
evid
np
higher
rate
relaps
intens
medic
treatment
high
rate
recurr
np
despit
surgic
medic
treatment
extrem
strong
associ
develop
classic
afr
presenc
underli
np
also
deserv
mention
distinguish
featur
crssnp
crswnp
reason
close
associ
unknown
mark
skew
afr
case
crswnp
categori
consid
anoth
argument
classifi
crswnp
distinct
crssnp
also
clinic
featur
classic
afr
consid
distinct
enough
subclassifi
crswnp
subgroup
group
one
repres
patient
classic
afr
group
repres
patient
anoth
question
highlight
divers
opinion
subject
polypoid
swell
alway
evolv
polyp
patient
polypoid
swell
consid
differ
polyp
acknowledg
earlier
intermedi
stage
np
format
address
current
classif
scheme
howev
stage
remain
undefin
need
studi
suggest
made
classifi
cr
term
presenc
absenc
mucos
infiltr
eosinophil
convers
basi
presenc
degranul
eosinophil
sinu
mucu
eosinophil
mucin
rhinosinus
term
chronic
eosinophil
sinus
syndrom
chronic
eosinophil
sinus
syndrom
also
suggest
emphas
role
eosinophil
diseas
rhinosinus
within
categori
eosinophil
cr
would
fall
classic
afr
eosinophil
inflamm
without
fungal
hypha
also
describ
eosinophil
mucin
rhinosinus
ferguson
aspirinexacerb
respiratori
diseas
consist
npscr
asthma
aspirin
sensit
eosinophil
granuloma
term
classif
scheme
fig
nearli
case
crswnp
subset
case
crssnp
would
fall
categori
eosinophil
inflamm
eosinophil
diseas
limit
predominantli
nasal
caviti
worth
mention
strong
associ
potenti
overlap
rhinosinus
includ
allerg
rhiniti
nonallerg
rhiniti
eosinophilia
syndrom
blood
eosinophilia
nonallerg
rhiniti
eosinophilia
syndrom
obvious
find
nasal
sinu
eosinophilia
common
element
group
divers
distinct
pathogen
syndrom
singl
classif
delin
find
presenc
atopi
mucos
edema
polyposi
fungal
hypha
noneosinophil
categori
would
includ
case
could
broken
distinct
subset
instanc
one
subset
would
includ
predomin
neutrophil
inflamm
well
associ
vasomotor
rhiniti
gerd
sarcoidosi
rational
subclassif
eosinophil
inflamm
import
featur
pathogenesi
cr
even
though
multipl
caus
factor
allerg
nonallerg
might
contribut
anoth
import
observ
strong
clinic
patholog
associ
eosinophil
categori
asthma
contrast
patholog
process
believ
like
cr
without
eosinophil
inflamm
impair
local
system
immun
innat
acquir
mucociliari
clearanc
sinu
ventil
propos
subclassif
incorpor
mani
concept
discuss
consensu
confer
howev
formal
adopt
level
tissu
eosinophil
need
defin
cr
eosinophil
inflamm
establish
furthermor
histolog
find
includ
quantif
eosinophil
readili
avail
patient
undergon
sinu
surgeri
classif
scheme
could
appli
clinic
without
obtain
sinu
tissu
recent
hypothesi
ponikau
et
al
describ
cr
eosinophil
fungal
rhinosinus
eosinophil
fungal
rhinosinus
discuss
hypothesi
base
find
fungal
hypha
associ
degranul
eosinophil
sinu
mucu
patient
cr
regardless
presenc
absenc
allergi
np
classic
featur
afr
author
propos
eosinophil
fungal
rhinosinus
account
vast
major
case
cr
propos
stimul
great
deal
controversi
one
contenti
issu
pertain
preval
find
fungal
hypha
sinu
mucu
level
hypha
would
consid
abnorm
use
greatli
refin
mucu
collect
stain
method
ponikau
et
al
found
fungal
hypha
mucu
nearli
patient
cr
confirmatori
result
recent
publish
graz
austria
use
similar
method
mucu
handl
histolog
stain
fungal
hypha
appar
differ
find
ponikau
et
al
earlier
report
might
due
differ
techniqu
use
mucu
handl
fungal
stain
controversi
issu
help
addit
studi
confirm
ponikau
et
al
observ
part
controversi
seem
stem
fact
inflammatori
process
stimul
fungal
hypha
previous
implic
small
subset
case
defin
afr
ponikau
et
al
propos
redefin
cr
afr
seem
dismiss
import
defin
small
subset
case
afr
howev
consensu
opinion
express
confer
term
classic
afr
retain
name
condit
classic
describ
distinct
immunolog
allerg
clinic
histolog
featur
see
previou
discuss
featur
ponikau
hypothesi
ultim
wide
accept
subgroup
patient
classic
afr
still
like
repres
distinct
clinic
subset
base
distinct
featur
given
emerg
data
ponikau
group
clear
role
fungi
cr
pathogenesi
could
assum
much
greater
import
previous
ascrib
basi
studi
classic
afr
classif
scheme
cr
intend
clinic
use
clinic
research
present
fig
distinct
factor
directli
evid
diseas
versu
factor
underli
diseas
somewhat
arbitrari
view
practic
mean
classifi
cr
import
distinguish
featur
scheme
controversi
bacteri
infect
regard
potenti
import
factor
crssnp
crswnp
similarli
underli
predispos
factor
diseas
mucu
recircul
humor
immun
defici
abnorm
mucociliari
function
allerg
rhiniti
extrem
import
list
anatom
abnorm
anecdot
list
predispos
factor
rhinosinus
exist
studi
support
role
import
question
aris
classif
scheme
strongli
certain
factor
bacteri
infect
associ
either
crssnp
crswnp
present
possibl
provid
definit
answer
question
precis
classif
patient
term
inflammatori
featur
name
eosinophil
inflammatori
featur
requir
evalu
sinu
tissu
sinu
mucu
case
inform
unavail
minim
clinic
classif
either
crssnp
crswnp
howev
research
purpos
committe
believ
inform
essenti
classifi
patient
symptom
assess
summari
statement
relev
rhinosinus
symptom
sever
time
cours
document
symptom
list
necessarili
differ
patient
acut
chronic
diseas
symptom
present
patient
rhiniti
analog
scale
could
use
report
individu
symptom
sever
score
total
rhinosinus
sever
score
global
sever
score
overal
qol
score
effect
current
past
treatment
histori
patient
present
possibl
diagnosi
rhinosinus
document
relev
symptom
sever
time
cours
sinus
often
preced
rare
occur
without
rhiniti
therefor
purpos
accuraci
definit
term
rhinosinus
prefer
appropri
symptom
note
sever
classif
relev
symptom
propos
first
develop
meet
sponsor
aaaai
list
symptom
associ
acut
bacteri
rhinosinus
tabl
viii
anoth
classif
develop
task
forc
rhinosinus
sponsor
aaohn
one
less
specif
etiolog
rhinosinus
tabl
ix
like
earlier
list
symptom
divid
major
minor
group
howev
clear
whether
categori
base
preval
rate
sever
degre
specif
symptom
addit
list
gener
necessarili
divid
symptom
major
minor
categori
suggest
symptom
facial
erythema
maxillari
toothach
high
specif
low
sensit
diagnosi
acut
communityacquir
bacteri
rhinosinus
other
state
symptom
seen
acut
rhinosinus
cr
although
might
vagu
patient
whose
symptom
persist
longer
time
although
singl
symptom
sign
might
fair
sensitivityspecif
combin
symptom
good
predict
valu
recent
relev
symptom
survey
modif
clinic
diagnost
criteria
suggest
aaohn
cr
anterior
posterior
purul
drainag
compress
singl
symptom
nasal
discharg
fever
omit
major
symptom
studi
acut
rhinosinus
rather
studi
patient
diseas
durat
week
longer
survey
given
patient
mean
age
year
percentag
patient
symptom
tabul
tabl
x
symptom
could
aggreg
nasal
symptom
nasal
obstruct
nasal
discharg
sens
smell
facial
symptom
facial
congest
facial
painpressureful
headach
oropharyng
symptom
halitosi
dental
pain
cough
ear
painpressur
system
symptom
fever
fatigu
cr
symptom
gener
seen
acut
rhinosinus
howev
patient
symptom
might
mild
consist
singl
symptom
postnas
drip
patient
might
awar
sinu
involv
eg
subject
concurr
rhinosinus
asthma
cr
common
symptom
import
differenti
diagnosi
headach
facial
pain
nasal
obstruct
discharg
headach
might
even
symptom
patient
eg
chronic
sphenoid
locat
headach
might
vari
depend
sinus
affect
howev
headach
facial
pain
gener
suggest
rhinosinus
absenc
sign
symptom
mani
caus
headach
manifest
anterior
face
includ
tension
migrain
cluster
rebound
headach
tempromandibular
joint
dysfunct
eye
diseas
problem
accommod
also
caus
periorbit
pain
tension
headach
common
type
headach
describ
tight
head
neck
aggrav
physic
activ
typic
present
symptom
migrain
absent
patient
tension
headach
often
believ
rhinosinus
pain
local
forehead
relief
obtain
overthecount
sinu
medic
migrain
headach
idiopath
recur
disord
attack
last
approxim
hour
characterist
migrain
unilater
locat
pulsat
qualiti
moderatetosever
intens
associ
nausea
phonophobia
photophobia
distinct
featur
migrain
aura
complex
neurolog
symptom
develop
onset
acut
headach
migrain
also
aggrav
routin
physic
activ
migrain
rhinosinus
present
time
migrain
headach
might
stimul
worsen
rhinosinus
nasal
obstruct
might
relat
structur
variat
septum
abnorm
nasal
pyramid
hypertrophi
edema
turbin
moderatetosever
anatom
deviat
septum
might
caus
constant
unilater
obstruct
tumor
might
also
present
symptom
nasal
blockag
unilater
nasal
obstruct
increas
time
possibl
pain
bloodi
discharg
suggest
possibl
sinist
patholog
nasal
paranas
nasopharyng
caviti
foreign
bodi
np
might
also
caus
unilater
obstruct
patient
rhinosinus
mucos
diseas
often
experi
altern
nasal
obstruct
usual
combin
anterior
discharg
postnas
discharg
mucu
might
vari
quantiti
qualiti
color
somewhat
depend
caus
disord
rhinosinus
symptom
sign
includ
seen
allerg
nonallerg
rhiniti
nasal
obstruct
nasal
discharg
hyposmia
symptom
consist
diagnosi
rhinosinus
relev
rhinosinus
symptom
item
need
individu
quantifi
help
defin
magnitud
patient
diseas
allow
refin
assess
intervent
score
simpl
dichotomi
indic
presenc
absenc
given
symptom
common
symptom
score
rang
clinic
trial
upper
respiratori
diseas
option
none
mild
moder
sever
likert
scale
would
rang
follow
noneabs
mild
mild
moder
sever
sever
scale
use
identifi
symptom
typic
problemat
patient
cr
tabl
xi
anoth
score
system
option
visual
analogu
scale
rang
symptom
maximum
sever
joint
task
forc
practic
paramet
repres
aaaai
american
colleg
allergi
asthma
immunolog
joint
council
allergi
asthma
immunolog
develop
method
assess
sever
symptom
allerg
rhiniti
includ
assess
nasal
symptom
sever
assess
nonnas
symptom
sever
global
assess
nasal
nonnas
symptom
sever
assess
qol
issu
relat
allerg
rhiniti
effect
advers
profil
current
past
rhiniti
medic
method
sever
assess
allerg
rhiniti
symptom
still
requir
intern
extern
valid
nonetheless
appear
potenti
assess
patient
manag
facilit
clinic
research
addit
use
method
guidelin
variat
suggest
could
adapt
evalu
rhinosinus
although
patient
might
character
sever
rhinosinus
mild
moder
sever
basi
one
domin
symptom
often
mix
degre
sever
individu
symptom
compris
full
clinic
pictur
recommend
joint
task
forc
practic
paramet
assess
individu
rhiniti
symptom
sever
use
visual
analog
scale
tabl
xii
report
rang
interv
data
gener
lower
measur
error
tabl
xiii
qol
import
consider
evalu
sever
rhinosinus
measur
recogn
effect
diseas
might
otherwis
report
patient
consid
clinician
scale
similar
use
symptom
sever
assess
use
tabl
xiv
visual
analog
scale
also
use
assess
effect
current
past
therapi
includ
overthecount
prescript
medic
complementari
altern
treatment
surgic
procedur
patient
rhinosinus
tabl
xv
failur
medic
use
consist
contrast
failur
one
compromis
poor
adher
regimen
durat
treatment
benefit
advers
effect
quantifi
complet
assess
rhinosinus
morbid
evalu
treatment
imper
physic
social
emot
problem
associ
condit
measur
valid
way
investig
strive
report
qol
data
fashion
clinic
meaning
sever
valid
rhinosinus
outcom
measur
instrument
seem
best
suit
particular
research
question
select
qol
import
consider
evalu
sever
rhinosinus
qol
measur
reflect
effect
symptom
patient
daili
life
outcom
research
studi
effect
divers
therapi
patient
outcom
increasingli
recogn
physician
thirdparti
payer
feder
govern
crucial
demonstr
treatment
effect
establish
patient
care
guidelin
one
key
featur
outcom
research
expand
definit
outcom
new
outcom
measur
use
outcom
research
includ
patientbas
measur
symptom
function
statu
social
emot
consequ
diseas
treatment
satisfact
care
outcom
research
refer
degre
chang
physic
mental
emot
social
state
gener
outcom
refer
outcom
intervent
chang
state
associ
treatment
intervent
outcom
also
chang
without
intervent
outcom
measur
focu
tradit
hard
biolog
measur
blood
pressur
laboratori
valu
soft
measur
pain
function
limit
healthrel
qol
assess
refer
descript
health
disabl
individu
perspect
qol
instrument
gener
includ
measur
physic
emot
impair
function
disabl
handicap
last
year
dramat
increas
use
qol
instrument
report
qol
outcom
unfortun
result
qol
instrument
easi
understand
integr
clinic
care
patient
multipl
problem
publish
literatur
regard
report
qol
studi
problem
includ
use
unfamiliar
scale
failur
explain
clinic
import
instrument
includ
failur
use
anchor
failur
describ
minim
clinic
import
differ
failur
differenti
infer
individu
infer
individu
versu
group
document
respons
chang
identifi
sampl
size
requir
statist
power
multipl
qol
end
point
longitudin
time
frame
whether
data
analyz
accord
origin
plan
health
statu
healthrel
qol
instrument
gener
diseas
specif
gener
measur
allow
comparison
across
differ
disord
sever
diseas
intervent
wherea
diseasespecif
scale
contain
item
relev
condit
studi
gener
health
score
similar
disabl
experienc
patient
back
pain
chronic
obstruct
pulmonari
diseas
angina
b
symptom
score
symptom
score
measur
sever
sinusitisrel
symptom
nasal
obstruct
problem
sens
smell
anterior
rhinorrhea
postnas
discharg
headach
facial
pain
sever
symptom
assess
visual
analogu
scale
patient
underw
function
endoscop
sinu
surgeri
statist
signific
differ
improv
symptom
c
rhinosinus
outcom
instrument
item
classifi
domain
item
respons
scale
magnitud
import
magnitud
scale
respons
score
import
scale
respons
score
product
magnitud
import
score
creat
symptomimpact
score
uniqu
patientspecif
score
rhinosinus
outcom
requir
approxim
minut
complet
document
respons
clinic
chang
domain
affect
order
sever
cohort
patient
rhinosinus
sleep
gener
problem
nasal
emot
rsom
score
correl
vital
gener
health
social
function
rolephys
subscal
sinonas
outcom
sinonas
outcom
deriv
rsom
elimin
item
import
scale
revis
make
score
easier
patient
request
identifi
item
import
hope
get
better
therapi
maximum
two
score
deriv
total
score
mean
score
item
import
score
mean
score
item
identifi
import
valid
demonstr
sensit
chang
item
identifi
import
higher
score
averag
show
greater
chang
score
treatment
item
identifi
import
use
outcom
studi
sponsor
aaaai
numer
pharmaceuticalsponsor
studi
current
use
royal
colleg
surgeon
unit
kingdom
nation
compar
audit
sinonas
surgeri
royal
colleg
surgeon
audit
outcom
studi
patient
undergo
sinonas
surgeri
followup
http
wwwrcsengacuksurgicalresearch
ceuprojectsongoingprojsinonasalhtml
e
chronic
sinus
survey
chronic
sinus
survey
durationbas
monitor
sinusitisspecif
outcom
symptombas
section
contain
follow
item
pain
pressur
congest
difficulti
breath
nose
nasal
discharg
post
nasal
drip
medicationbas
section
contain
item
antibiot
prescript
nasal
spray
sinu
medic
pill
form
sever
symptom
scale
none
sever
total
score
calcul
use
score
algorithm
normal
score
worst
best
f
rsdi
rsdi
broadbas
diseasespecif
instrument
compris
item
use
evalu
physic
emot
social
disabl
cr
without
polyp
aspirin
sensit
triad
allerg
rhiniti
nonallerg
rhiniti
acut
rhinosinus
recurr
acut
rhinosinus
septal
deviat
obstruct
item
rsdi
valid
testretest
cronbach
coeffici
spearman
correl
rsdi
use
evalu
patient
varieti
nasal
disord
sinu
disord
compar
effect
disord
physic
function
emot
domain
criteria
choos
particular
qol
outcom
measur
decid
qol
outcom
measur
use
particular
studi
recommend
follow
criteria
use
demonstr
testretest
reliabl
valid
measur
purport
measur
respons
chang
eas
interpret
result
degre
respond
burden
intend
purpos
outcom
measur
ie
diagnost
assess
respons
therapi
prognost
summari
complet
assess
rhinosinus
evalu
treatment
imper
physic
function
emot
problem
associ
condit
measur
valid
way
without
incorpor
good
qol
instrument
good
rhinosinus
outcom
research
mani
pitfal
report
qol
inform
investig
strive
report
qol
data
fashion
clinic
meaning
sever
valid
rhinosinus
outcom
measur
instrument
seem
best
suit
particular
research
question
select
anterior
rhinoscopi
basic
tool
physic
examin
relat
determin
exist
patholog
sinonas
passag
best
evalu
patient
decongest
topic
decongest
howev
even
method
examin
nasal
passag
beyond
anterior
portion
limit
nasal
endoscopi
help
identifi
erythema
edema
polyp
polypoid
swell
crust
eosinophil
mucin
mucopu
frank
pu
deep
nasal
caviti
use
assess
treatment
patient
refractori
chronic
symptom
patient
impend
exist
complic
rhinosinus
cultur
obtain
endoscop
less
invas
associ
less
morbid
howev
techniqu
prove
equival
antral
punctur
children
sinu
infect
rhinosinus
tradit
diagnos
care
histori
physic
examin
techniqu
reveal
import
inform
necessari
diagnosi
treatment
monitor
howev
symptom
provid
inform
differ
well
correl
endoscopi
imag
patient
might
given
improp
diagnosi
might
manag
improperli
basi
histori
alon
therefor
object
measur
increasingli
perceiv
necessari
accur
determin
presenc
absenc
rhinosinus
lead
method
object
assess
nasal
endoscopi
sinu
imag
ct
endoscopi
alon
use
determin
normalci
rhinosinus
occur
sinu
area
endoscopi
detect
similarli
abnorm
seen
imag
present
without
associ
symptom
therefor
subject
object
assess
valu
anterior
rhinoscopi
basic
tool
physic
examin
specif
relat
determin
exist
patholog
sinonas
passag
best
evalu
patient
decongest
topic
decongest
oxymetazolin
neosynephrin
decongest
clinician
evalu
appear
anterior
nasal
passageway
typic
decongest
middl
turbin
directli
visual
anterior
rhino
copi
howev
examin
nasal
passag
beyond
limit
use
method
septal
deviat
seen
normal
popul
obstruct
complet
examin
assess
anterior
rhinoscopi
nasal
endoscopi
nasal
endoscopi
play
import
role
diagnosi
rhinosinus
also
assist
treatment
clinician
current
use
nasal
endoscopi
hold
tenet
true
patient
symptom
unreli
gaug
diseas
endoscopi
facilit
proper
diagnosi
detect
diseas
miss
routin
histori
physic
examin
even
miss
imag
studi
discolor
drainag
yellow
green
repres
patholog
process
drain
nasal
passageway
properli
obtain
endoscop
cultur
use
identifi
organ
might
respons
certain
form
rhinosinus
import
role
endoscopi
assess
treatment
patient
refractori
chronic
symptom
patient
impend
exist
complic
rhinosinus
endoscopi
well
toler
without
risk
contrast
anterior
rhinoscopi
endoscopi
introduc
brilliant
illumin
dark
caviti
permit
magnifi
direct
visual
mucosa
turbin
postsurg
patient
sinus
nasal
endoscopi
help
identifi
erythema
edema
polyp
polypoid
swell
crust
eosinophil
mucin
mucopu
frank
pu
deep
nasal
caviti
examin
also
identifi
pu
eman
middl
meatu
sphenoethmoid
recess
nasopharynx
type
endoscop
avail
evalu
sinonas
passag
flexibl
fiberopt
endoscop
rigid
telescop
differ
mainli
term
patient
toler
safeti
regard
patient
comfort
direct
access
sinu
caviti
flexibl
endoscopi
gener
superior
rigid
endoscopi
howev
imag
clariti
facil
obtain
cultur
sampl
tissu
abil
control
epistaxi
abil
perform
surgeri
superior
rigid
endoscopi
photo
document
endoscop
evalu
photoendoscopi
use
research
tool
despit
differ
patient
comfort
even
rigid
nasal
endoscopi
well
toler
evidenc
unpublish
data
collect
evalu
microbiolog
nasal
caviti
healthi
medic
student
subject
underw
topic
decongest
anesthesia
follow
rigid
nasal
endoscopi
ask
rate
overal
experi
rigid
nasal
endoscopi
cultur
sampl
scale
averag
subject
rate
experi
toler
mildli
uncomfort
although
gener
safe
welltoler
procedur
common
advers
effect
endoscopi
patient
discomfortpain
epistaxi
vasovag
event
regard
patient
comfort
endoscopi
worth
note
appear
decreas
sensit
nasal
passageway
patient
nasal
polyp
part
might
explain
data
suggest
substanc
p
level
deplet
polyp
tissu
inform
also
help
support
fact
patient
unreli
gaug
diseas
sever
rare
complic
report
albeit
rare
offic
endoscopi
includ
orbit
hematoma
death
associ
suction
near
carotid
arteri
indic
nasal
endoscopi
offic
evalu
includ
assess
symptomat
patient
refractori
appropri
empir
therapi
unilater
diseas
without
septal
deviat
sever
disabl
symptom
endoscopi
also
indic
complic
suspect
patient
immunocompromis
sinu
surgeri
trauma
although
controversi
exist
valu
endoscop
obtain
cultur
mani
leader
studi
nasal
sinu
diseas
collect
guid
therapi
cultur
obtain
skill
experienc
endoscopist
otherwis
result
specimen
could
mislead
endoscop
sampl
perform
either
steril
swab
aspir
steril
trap
sampl
sinu
secret
must
obtain
one
paranas
sinus
without
contamin
normal
respiratori
oral
flora
determin
microbiolog
rhinosinus
specimen
collect
mean
sinu
punctur
endoscop
sinu
aspir
tradit
bacteri
specimen
sinus
collect
sinu
aspir
maxillari
sinu
access
nonendoscop
approach
maxillari
sinu
either
canin
fossa
inferior
meatu
nasal
vestibul
heavili
colon
pathogen
bacteria
especi
aureu
accordingli
steril
nasal
vestibul
area
beneath
inferior
nasal
turbin
recommend
contamin
nasal
flora
isol
sinu
aspir
might
misconstru
pathogen
topic
anesthet
use
punctur
site
acut
infect
defin
recoveri
bacteri
speci
high
densiti
ie
coloni
count
least
cfuml
avoid
misinterpret
cultur
result
quantit
definit
increas
probabl
organ
recov
maxillari
sinu
aspir
truli
repres
situ
infect
contamin
fact
sinu
aspir
infect
sinus
associ
coloni
count
excess
cfuml
quantit
cultur
perform
gram
stain
aspir
specimen
afford
semiquantit
data
bacteria
readili
appar
gram
stain
approxim
bacteri
densiti
cfuml
case
antral
punctur
show
least
cfuml
pathogen
gram
stain
demonstr
either
organ
white
blood
cell
organ
white
blood
cell
gram
stain
especi
help
bacteria
seen
smear
specimen
fail
grow
standard
aerob
cultur
techniqu
case
anaerob
organ
fastidi
bacteria
bacteri
biofilm
antibioticsuppress
infect
suspect
perform
gram
stain
also
permit
assess
local
inflammatori
respons
presenc
mani
white
blood
cell
associ
posit
bacteri
cultur
high
densiti
make
like
bacteri
infect
present
gram
stain
easili
differenti
neutrophil
eosinophil
therefor
eosinophilrich
smear
bacteria
would
interpret
show
mani
white
blood
cell
mani
laboratori
altern
pauciti
absenc
white
blood
cell
associ
presenc
posit
cultur
low
densiti
suggest
bacteria
contamin
cultur
rather
caus
infect
b
endoscop
specimen
recent
interest
obtain
cultur
middl
meatu
endoscop
surrog
cultur
sinu
aspir
endoscop
obtain
cultur
less
invas
associ
less
morbid
unfortun
healthi
children
middl
meatu
shown
colon
bacteri
speci
pneumonia
h
influenza
catarrhali
commonli
recov
children
sinu
infect
accordingli
techniqu
controversi
potenti
misinterpret
children
recent
studi
bacteri
speci
recov
middl
meatal
sampl
healthi
adult
cn
corynebacterium
speci
aureu
organ
serv
commens
potenti
pathogen
aureu
sever
studi
adult
shown
good
correl
cultur
middl
meatu
sinu
aspir
patient
acut
sinus
especi
purul
seen
middl
meatu
howev
studi
cn
usual
interpret
nonpathogen
acut
sinus
talbot
et
al
correl
result
endoscop
obtain
cultur
cultur
obtain
maxillari
sinu
aspir
report
situat
punctur
demonstr
cn
greater
cfuml
howev
swab
middl
meatu
grew
cn
patient
interpret
pathogen
aureu
difficult
two
patient
greater
cfuml
correl
endoscop
swab
howev
addit
patient
agreement
site
rare
instanc
neither
sinu
aspir
specimen
obtain
endoscop
suffici
diagnosi
sinu
infect
instanc
biopsi
sinu
mucosa
broth
cultur
appropri
stain
might
requir
ascertain
microbiolog
summari
statement
although
rhinosinus
diagnos
major
patient
use
clinic
judgment
patient
recurr
complic
sinu
diseas
might
requir
imag
studi
studi
j
allergi
clin
immunol
volum
number
absolut
requir
patient
undergo
function
endoscop
sinu
surgeri
ct
major
role
rhinosinus
defin
anatomi
sinus
surgeri
aid
diagnosi
manag
recurr
rhinosinus
csr
although
mri
display
boni
anatomi
ct
provid
excel
display
mucosa
superior
distinguish
bacterialvir
inflammatori
diseas
fungal
concret
critic
assess
rel
valu
variou
imag
modal
rhinosinus
must
consid
technic
merit
type
studi
also
propos
applic
studi
diseas
diagnosi
risk
stratif
quantif
diseas
respons
medic
surgic
intervent
diseas
prognost
standard
plain
film
nasal
caviti
paranas
sinus
although
plain
film
technolog
might
less
costli
compar
diagnost
measur
fall
short
provid
adequ
diagnost
inform
plain
film
fail
provid
inform
requir
patient
anatomi
paranas
sinu
perimet
extent
inflammatori
diseas
also
plain
film
inadequ
guid
surgeri
although
plain
film
limit
util
screen
tool
children
appropri
current
view
would
modal
useless
demonstr
region
morpholog
preclud
accur
represent
extent
diseas
gener
margin
benefit
sinu
plain
film
insuffici
justifi
exposur
radiat
regardless
low
might
afford
technolog
ct
major
role
rhinosinus
defin
anatomi
sinus
surgeri
aid
diagnosi
manag
recurr
rhinosinus
cr
given
resolut
region
boni
anatomi
mucosa
prove
optim
modal
provid
anatom
roadmap
surgeon
perform
function
endoscop
sinu
surgeri
inform
afford
coron
plane
proven
correl
endoscop
inform
favor
plane
studi
patient
anatomi
plan
surgic
procedur
develop
imageguid
surgic
equip
base
primarili
ct
inform
recent
sever
author
attempt
use
ct
inform
specif
volum
inflammatori
diseas
within
paranas
sinus
attempt
stage
patient
rhinosinus
variou
stage
system
primarili
focus
presenc
quantiti
inflammatori
diseas
within
paranas
sinu
accept
stage
system
lundmackay
tabl
xvi
unfortun
system
current
avail
allow
clinician
show
judg
evolut
diseas
indic
prognosi
similarli
date
meaning
correl
determin
symptom
presenc
inflammatori
diseas
within
variou
sinus
challeng
ct
stage
although
result
lundmackay
system
appear
reproduc
still
clinic
challeng
address
method
classif
current
classif
system
lack
suffici
level
gradat
track
progress
reduct
diseas
volum
adequ
precis
anoth
problem
classif
current
use
correl
well
symptom
possibl
consid
ostiomeat
channel
quantifi
volum
diseas
add
clinic
valu
futur
classif
system
stage
system
provid
object
mean
quantifi
volum
inflammatori
mucosa
opacif
easi
use
requir
formal
train
high
reproduc
demonstr
interobserv
intraobserv
studi
abl
quantifi
patenc
ostiomeat
passageway
ie
specif
ostiomeat
tight
spot
frontal
recess
infundibulum
middl
meatu
sphenoethmoid
recess
quantif
patenc
structur
would
offer
import
addit
inform
stage
diseas
assess
progress
regress
ostiomeat
patenc
might
import
indic
respons
medic
surgic
treatment
howev
formal
shown
precis
quantif
might
also
provid
better
measur
regress
diseas
tight
spot
associ
reduct
volum
inflammatori
diseas
even
though
imag
modal
display
boni
anatomi
ct
provid
excel
display
mucosa
superior
display
extens
diseas
beyond
paranas
sinus
orbit
intracrani
compart
bacteri
viral
inflamm
indistinguish
howev
mri
superior
differenti
infecti
inflammatori
diseas
bacteri
viral
fungal
concret
effect
technolog
isol
presenc
neoplasia
morpholog
area
given
sensit
document
presenc
fluid
mri
distinguish
inflammatori
diseas
edemat
mucosa
seen
nasal
cycl
addit
mri
technolog
less
readili
avail
expens
lengthier
procedur
ct
two
crosssect
imag
modal
avail
ct
mri
abl
demonstr
mucos
inflammatori
diseas
therefor
potenti
use
diseas
stage
lundmackay
system
object
reproduc
major
drawback
inabl
subgrad
volum
inflammatori
diseas
grade
repres
degre
sinu
involv
greater
less
evalu
specif
medic
therapeut
agent
grade
diseas
sinu
involv
cure
reduc
grade
howev
grade
diseas
involv
reduc
substanti
improv
classif
still
grade
suggest
chang
furthermor
stage
system
take
account
patenc
ostiomeat
channel
issu
easili
address
stratifi
grade
note
patenc
tight
spot
ie
frontal
recess
middl
meatu
infundibulum
sphenoethmoid
recess
modif
cours
evalu
reproduc
prognost
valu
tabl
xvii
mri
although
expens
ct
could
use
assess
volum
inflammatori
mucosa
bright
signal
intens
imag
isol
comput
workstat
reconstruct
comput
provid
quantit
estim
volum
potenti
confound
edemat
mucosa
nasal
cycl
signal
inflammatori
diseas
cycl
side
side
edemat
mucosa
separ
infect
mucosa
must
includ
reconstruct
howev
one
would
assum
hope
correctli
volum
mucosa
cycl
nasal
caviti
constant
individu
summari
statement
nasal
sinu
challeng
provid
mean
studi
pathophysiolog
diseas
interact
among
nose
sinus
lower
airway
nasal
challeng
also
use
confirm
allergi
assess
nasal
threshold
respons
studi
mediat
inflammatori
cell
cytokin
nasal
sinu
challeng
studi
contribut
understand
pathophysiolog
nasal
sinu
diseas
well
understand
connect
upper
lower
airway
baroodi
et
al
interest
interact
nose
paranas
sinus
first
perform
doubleblind
placebocontrol
crossov
trial
healthi
nonallerg
subject
assess
nasal
versu
sinu
respons
histamin
subject
treat
loratadin
placebo
day
underw
nasal
challeng
histamin
twentyfour
hour
later
receiv
medic
cathet
place
sinu
caviti
subject
underw
sinu
challeng
histamin
surprisingli
patient
receiv
placebo
nasal
challeng
histamin
led
increas
vascular
leak
indic
increas
level
albumin
nasal
lavag
specimen
treat
loratadin
h
antihistamin
effect
histamin
challeng
block
although
similar
effect
note
sinu
challeng
sinu
mucosa
time
less
sensit
histamin
compar
nasal
mucosa
contralater
respons
indic
nasonas
reflex
also
evalu
although
nasal
challeng
produc
signific
reflex
effect
note
sinu
challeng
studi
show
feasibl
challeng
sinu
directli
suggest
differ
respons
sinu
nasal
mucosa
stimulu
research
also
investig
whether
allergen
challeng
nose
abil
induc
inflammatori
chang
sinus
pelikan
pelikanfilipek
conduct
nasal
challeng
antigen
patient
chronic
maxillari
sinus
result
posit
nasal
respons
patient
measur
use
rhinometri
interestingli
challeng
show
increas
mucos
edema
opacif
maxillari
sinus
plain
radiograph
conclud
role
nasal
allergi
patient
chronic
maxillari
sinus
anoth
studi
baroodi
et
al
evalu
effect
antigen
challeng
nose
inflamm
within
sinu
use
sinojet
ato
medic
distribut
bivona
medic
technolog
gari
ind
instrument
use
obtain
sinu
lavag
fluid
maxillari
sinu
found
nasal
allergen
challeng
induc
eosinophil
sinu
mucos
respons
seen
control
challeng
anoth
studi
subject
challeng
assess
effect
nasal
allergen
challeng
ipsilater
versu
contralater
sinu
although
eosinophil
present
side
number
eosinophil
significantli
less
contralater
side
signific
increas
maxillari
sinu
eosinophil
also
found
allergi
season
compar
seen
patient
season
confirm
find
nasal
challeng
studi
overal
result
suggest
sinu
inflamm
occur
nasal
allergen
challeng
adkin
et
al
studi
abil
inhal
antigen
enter
sinus
radiolabel
ragwe
pollen
spray
intranas
nonallerg
subject
use
ct
scan
radiolabel
ragwe
detect
nose
suggest
studi
pollen
inhal
maxillari
sinu
howev
discuss
addit
advanc
understand
sinu
pathophysiolog
nasalsinu
challeng
import
applic
rhinosinus
research
instanc
nasal
challeng
lysineaspirin
use
confirm
histori
aspirin
sensit
nasal
challeng
also
use
confirm
allergi
assess
nasal
threshold
respons
studi
inflammatori
cell
cytokin
involv
allerg
inflamm
exampl
keith
colleagu
perform
allergen
challeng
patient
np
posit
skin
test
respons
found
insensit
challeng
impli
allergi
import
pathophysiolog
group
patient
np
sum
nasal
sinu
challeng
provid
mean
studi
pathophysiolog
diseas
interact
among
nose
sinus
lower
airway
although
current
indic
might
futur
valu
defin
patient
enter
clinic
trial
studi
sinus
summari
statement
integr
airway
syndrom
also
call
chronic
inflammatori
respiratori
syndrom
wide
spectrum
sever
low
end
manifest
clinic
evid
form
rhiniti
high
end
manifest
includ
asthma
possibl
rhinosinus
link
upper
lower
respiratori
tract
strongli
support
allerg
rhiniti
nonallerg
rhiniti
risk
factor
asthma
allerg
rhiniti
almost
ubiquit
asthma
even
absenc
nasal
symptom
nasal
mucosa
patient
asthma
show
evid
inflamm
rhiniti
asthmat
patient
tend
sever
rhiniti
nonasthmat
patient
allerg
reaction
inflammatori
consequ
appear
propag
system
therefor
interact
nasal
sinu
lower
airway
might
repres
manifest
system
process
nasal
airway
sinu
caviti
pharynx
larynx
trachea
intrathorac
airway
part
one
conduit
common
embryolog
origin
part
appear
special
function
part
highli
integr
although
ill
might
affect
select
part
sever
other
manifest
entir
respiratori
tract
chronic
allerg
respiratori
syndrom
perhap
nonallerg
counterpart
exampl
panairway
afflict
chronic
rhiniti
rhinosinus
asthma
consid
compon
syndrom
independ
nosolog
entiti
model
propos
integr
mani
epidemiolog
pathophysiolog
clinic
observ
rhiniti
asthma
similar
model
could
propos
integr
rhiniti
rhinosinus
well
rhinosinus
asthma
premis
model
chronic
allerg
respiratori
syndrom
spectrum
sever
low
end
manifest
clinic
evid
form
rhiniti
high
end
manifest
includ
asthma
possibl
rhinosinus
reason
nose
center
syndrom
constitut
primari
deposit
site
aeroallergen
presenc
rhiniti
alon
lack
clinic
manifest
syndrom
lower
airway
paranas
sinus
interpret
lack
involv
lower
airway
individu
allerg
rhiniti
repeatedli
found
inflam
even
remodel
increas
thick
reticular
basement
membran
compar
healthi
control
subject
also
lower
airway
hyperrespons
detect
signific
number
individu
allerg
rhiniti
without
lower
airway
symptom
sever
observ
support
aforement
model
first
allerg
rhiniti
nonallerg
rhiniti
risk
factor
asthma
crosssect
longitudin
studi
second
rhiniti
almost
ubiquit
asthma
furthermor
nasal
mucosa
patient
asthma
show
evid
inflamm
even
absenc
nasal
symptom
third
rhiniti
asthmat
patient
tend
sever
rhiniti
nonasthmat
patient
although
concept
adequ
investig
avail
data
still
preliminari
form
recent
epidemiolog
evid
provid
support
theori
final
data
patholog
clinicoepidemiolog
studi
suggest
asthmat
patient
sever
asthma
rhiniti
track
parallel
addit
aspect
relationship
nasal
lower
airway
diseas
context
chronic
allerg
respiratori
syndrom
event
take
place
nasal
caviti
might
affect
lower
airway
nasal
allerg
reaction
induc
local
provoc
exampl
result
increas
respons
lower
airway
even
late
reduct
lung
function
invers
treatment
allerg
rhiniti
topic
glucosteroid
shown
sever
studi
improv
variou
asthma
outcom
howev
mechan
appar
interact
nasal
lower
airway
clear
obvious
mani
function
nose
known
benefit
lower
airway
would
surpris
deterior
improv
function
account
interact
hand
allerg
reaction
inflammatori
consequ
appear
propag
system
interact
nasal
lower
airway
might
repres
manifest
system
compon
data
relat
sinu
diseas
asthma
far
less
extens
howev
indic
similar
relationship
asthma
rhinosinus
asthma
rhiniti
exampl
almost
ubiquit
presenc
paranas
sinu
abnorm
patient
moderatetosever
asthma
report
studi
use
comput
tomographi
commonli
coexist
test
pulmonari
function
patient
rhinosinus
alway
consid
evid
eosinophilia
sinu
mucosa
stronger
patient
rhinosinus
asthma
oppos
rhinosinus
alon
medic
surgic
treatment
sinu
diseas
appear
benefici
effect
asthma
outcom
studi
report
find
random
outcom
frequent
subject
thu
link
upper
lower
airway
fulli
understood
addit
care
mechanist
therapeut
studi
need
conduct
clarifi
relationship
rhinosinus
integr
respiratori
syndrom
issu
compromis
advanc
rhinosinus
research
rhinosinus
trial
need
concern
time
issu
season
pattern
durat
acut
versu
chronic
studi
sever
consensu
document
publish
recent
year
attempt
defin
rhinosinus
sinus
individu
articl
also
attempt
develop
definit
despit
diseas
definit
clinic
trial
epidemiolog
survey
larg
propos
ad
hoc
basi
exampl
studi
design
demonstr
efficaci
novel
antibiot
frequent
studi
subject
acut
symptom
combin
presenc
fluid
maxillari
sinus
demonstr
basi
airfluid
level
plain
radiographi
ct
scan
given
regulatori
guidelin
class
drug
approv
definit
understand
howev
mani
patient
present
similar
spectrum
acut
symptom
treat
empir
basi
without
confirmatori
imag
test
review
publish
clinic
trial
clear
even
acut
maxillari
paradigm
list
inclus
exclus
criteria
inconsist
regard
demograph
popul
studi
medic
prohibit
studi
rang
concomit
medic
permit
without
consensu
definit
surpris
basic
epidemiolog
unclear
larg
epidemiolog
survey
might
suffici
patient
report
diagnosi
cr
includ
categori
other
ct
scan
object
confirm
might
requir
similarli
varieti
outcom
scale
instrument
use
issu
discuss
gener
review
main
issu
surround
placebo
ethic
technic
feasibl
certain
clear
situat
placebo
group
would
uneth
eg
acut
sever
bacteri
infect
antibiot
treatment
indic
case
standard
antibiot
gener
appropri
use
posit
control
case
suspect
acut
bacteri
sinus
placebocontrol
trial
might
reason
appropri
rescu
measur
includ
protect
patient
trial
discontinu
patient
trial
could
valid
efficaci
outcom
variabl
addit
clinic
trial
demonstr
antibiot
effect
rhinosinus
case
placebo
control
group
might
ethic
also
adjunct
prophylact
agent
evalu
often
possibl
design
appropri
placebocontrol
studi
technic
difficulti
occur
evalu
differ
formul
topic
versu
system
agent
oral
versu
parenter
agent
clear
infect
select
placebo
group
might
depend
whether
group
advers
affect
allow
underli
diseas
process
eg
inflamm
continu
untreat
baselin
variabl
differ
studi
group
poorli
defin
durat
discret
episod
long
placebo
runin
period
might
feasibl
effect
topic
agent
nose
sinus
consid
conduct
clinic
trial
sever
european
studi
evalu
treatment
modal
rhinosinus
use
topic
aadrenerg
agonist
permit
concomit
medic
refer
confound
trial
data
class
drug
shown
increas
sinu
ostial
diamet
even
incid
use
medic
studi
group
similar
addit
effect
might
separ
effect
studi
drug
larg
bodi
literatur
discuss
effect
preserv
nasal
mucosa
overal
conclus
deriv
combin
vitro
anim
studi
somewhat
controversi
appli
clinic
practic
ciliari
activ
might
reduc
infect
per
se
ad
effect
caus
preservativecontain
topic
compound
might
inconsequenti
studi
infecti
rhinosinus
topic
agent
introduc
nose
pass
retrograd
paranas
sinus
intact
osteomeat
unit
sever
imag
studi
conduct
fail
demonstr
retrograd
transport
fact
must
consid
interpret
result
studi
topic
agent
rhinosinus
outcom
might
differ
sinu
surgeri
compar
studi
administ
salin
mean
nasal
instil
demonstr
reduct
nasal
blood
flow
measur
mean
laserdoppl
velocimetri
intranas
salin
shown
mild
decongest
action
use
even
seemingli
benign
spray
control
studi
rhinosinus
addit
vehicl
use
drug
polyethylen
glycol
act
wet
agent
produc
benefici
effect
nasal
symptom
test
therapeut
agent
use
vehicl
requir
appropri
control
ultim
potenti
benefici
advers
effect
compon
drug
product
drug
taken
consider
analyz
valu
compound
treatment
rhinosinus
clinic
effect
repeat
dose
variou
medic
might
differ
effect
seen
administr
singl
dose
event
receptor
downregul
induct
pharmacolog
toler
issu
compromis
use
system
agent
rhinosinus
includ
advers
effect
organ
problem
drugdrug
interact
use
certain
marker
eg
imag
studi
might
inappropri
end
point
clinic
trial
correl
well
clinic
end
point
ie
symptom
studi
therapeut
agent
treatment
rhiniti
individu
composit
symptom
score
well
accept
end
point
studi
nonantibiot
drug
manag
rhinosinus
condit
poor
correl
ct
find
symptom
ct
find
alon
use
surrog
assess
efficaci
physician
routin
treat
entiti
acut
chronic
rhiniti
rhinosinus
empir
basi
symptomat
present
establish
patient
rhinosinus
experi
exacerb
physician
often
diagnos
prescrib
without
physic
examin
littl
evid
physic
examin
help
establish
diagnosi
patient
present
typic
symptom
rhinosinus
patient
refractori
therapi
symptom
atyp
detail
physic
examin
gener
indic
case
referr
specialist
perform
radiograph
imag
flexibl
rigid
nasal
endoscopi
might
appropri
experi
evolv
use
coron
ct
imag
sinus
accept
appropri
time
ct
scan
crucial
gwaltney
et
al
show
posit
scan
could
demonstr
acut
upper
respiratori
tract
infect
cr
scan
taken
demonstr
extent
residu
diseas
maxim
pharmacotherapi
defin
anatomi
surgeri
appropri
sever
attempt
devis
stage
system
defin
extent
diseas
develop
guid
surgic
stage
valid
context
assess
natur
histori
diseas
assess
effect
nonsurg
intervent
clinic
trial
need
conduct
increas
incid
upper
respiratori
tract
infect
obtain
adequ
number
clinic
trial
subject
acut
episod
rhinosinus
season
epidemiolog
patient
cr
well
defin
patient
underli
allerg
diathesi
might
experi
exacerb
time
allergen
sensit
present
environ
might
acut
infecti
episod
present
time
increas
airway
reactiv
could
due
predisposit
induc
allerg
inflamm
independ
effect
studi
conduct
differ
part
world
durat
season
allergi
specif
pollen
vari
lead
dispar
clinic
effect
studi
year
report
studi
effect
intervent
incid
exacerb
environment
variabl
might
chang
prolong
studi
period
could
difficult
assess
control
similarli
seek
past
histori
acut
rhinosinus
episod
frequent
difficult
pinpoint
discret
episod
even
difficult
document
whether
acut
infecti
episod
episod
might
treat
empir
telephon
consult
rare
object
confirm
activ
pathogen
pragmat
often
reason
defin
set
symptom
consist
sinu
infect
assum
patient
recogn
retrospect
categor
sinu
infect
furthermor
current
medic
practic
includ
diagnos
treat
empir
one
option
would
design
clinic
trial
protocol
basi
reallif
scenario
limit
understand
natur
histori
variou
type
rhinosinus
decis
specif
end
point
followup
time
frame
intervent
might
arbitrari
effect
allerg
inflamm
paranas
sinus
great
interest
full
effect
remain
poorli
understood
howev
entiti
would
current
character
allerg
rhinosinus
pelikan
pelikanfilipek
describ
seri
case
demonstr
acut
revers
opacif
maxillari
sinus
topic
antigen
challeng
studi
examin
sinu
caviti
patholog
sever
studi
report
higher
incid
acut
sinus
episod
patient
allerg
rhiniti
compar
without
allerg
rhiniti
clear
associ
allerg
rhiniti
exacerb
sinu
infect
effect
allergen
immunotherapi
would
import
studi
similarli
effect
immunomodul
intervent
studi
given
fact
reason
believ
immunotherapi
could
confound
assess
treatment
evalu
especi
allergen
dose
stabl
season
effect
immunotherapi
patient
enter
longterm
clinic
trial
determin
assess
effect
surgeri
cr
pose
special
challeng
chanc
publish
case
might
repres
best
result
individu
surgeon
group
highli
experienc
given
techniqu
case
seri
bilater
intranas
sphenoethmoidectomi
publish
outcom
endoscop
surgeri
also
well
describ
sever
studi
might
difficult
compar
techniqu
outcom
differ
surgeon
one
key
point
surgic
outcom
depend
degre
mucos
diseas
present
oper
indic
perform
sinu
surgeri
might
also
vari
somewhat
case
seri
patient
undergo
surgeri
despit
rel
normal
sinu
appear
preoper
sinu
ct
scan
clear
result
compar
still
difficult
medic
practition
decid
basi
refer
given
patient
surgeon
anecdot
satisfact
ethic
consider
must
evalu
parallelgroup
clinic
trial
human
subject
one
group
get
sham
surgeri
one
interest
studi
nasal
polyposi
involv
oper
unaffect
side
although
difficult
blind
sham
control
surgic
treatment
possibl
import
consid
random
surgeri
versu
surgeri
avail
rescu
medic
period
time
b
develop
effect
drug
trial
scheme
rhinosinus
summari
statement
trial
acut
rhinosinus
like
carri
primari
care
offic
set
sophist
diagnost
techniqu
ct
mri
might
readili
avail
therefor
medic
histori
particular
sometim
physic
examin
primarili
use
diagnos
condit
therapeut
efficaci
must
demonstr
adequ
wellcontrol
studi
show
intervent
effect
purport
prospect
choic
end
point
critic
part
drug
develop
efficaci
end
point
trial
form
basi
approv
clinic
relev
valid
direct
major
rhinosinus
trial
new
form
therapi
new
indic
alreadi
exist
treatment
done
patient
acut
rhinosinus
cr
seriou
often
debilit
diseas
howev
poor
pharmacolog
respons
rate
seen
patient
popul
well
lack
understand
diseas
classif
made
accur
efficaci
assess
difficult
therefor
clearer
definit
categori
cr
urgent
need
target
correct
patient
popul
essenti
design
studi
ensur
realworld
assess
intervent
research
develop
clinic
trial
design
need
set
diagnost
paramet
patient
provid
meaning
clinic
result
includ
patient
rhinosinus
might
mean
distinguish
viral
bacteri
diseas
well
acut
rhinosinus
cr
trial
acut
rhinosinus
like
carri
primari
care
offic
set
sophist
diagnost
techniqu
ct
mri
might
readili
avail
purpos
research
patient
symptom
last
less
day
includ
trial
presum
bacteri
infect
symptom
resolv
day
usual
indic
viral
rhinosinus
symptom
evalu
includ
purul
drainag
nasal
congest
facial
pain
headach
even
criteria
appli
consider
must
given
high
rate
spontan
resolut
approxim
popul
acut
presum
bacteri
rhinosinus
therefor
unless
sampl
size
larg
enough
effect
power
studi
result
might
fail
demonstr
drug
efficaci
pharmacolog
studi
rhinosinus
either
involv
symptomrelief
drug
cur
drug
symptom
reliev
corticosteroid
antihistamin
decongest
mucolyt
primari
outcom
variabl
use
evalu
efficaci
improv
symptom
sign
cur
drug
antibiot
outcom
variabl
could
cure
rate
failur
recurr
rate
import
outcom
measur
type
drug
time
improv
number
symptomfre
day
diseas
burden
qol
also
import
assess
depend
type
drug
studi
could
also
design
evalu
prophylaxi
safeti
studi
often
design
focu
efficaci
studi
need
random
doubleblind
control
key
measur
efficaci
type
studi
symptom
resolut
control
group
essenti
quantifi
placebo
effect
durat
treatment
depend
diseas
studi
acut
rhinosinus
studi
screen
phase
would
short
acut
natur
diseas
treatment
period
also
brief
eg
week
studi
patient
cr
requir
treatment
much
longer
typic
month
differenti
crssnp
crswnp
focus
differ
symptom
pattern
studi
assess
prophylaxi
need
run
least
month
treatment
period
end
followup
period
necessari
ensur
symptom
truli
resolv
inclus
criteria
includ
predefin
age
limit
either
adult
pediatr
studi
clearli
defin
symptom
acut
rhinosinus
day
common
exclus
criteria
includ
immunocompromis
patient
patient
ciliari
disord
sort
perman
local
obstruct
acut
studi
patient
cr
confound
factor
usual
exclud
season
pollen
allergi
larg
nasal
polyp
atroph
rhiniti
outcom
measur
vari
depend
drug
class
studi
exist
sinus
studi
focus
antibiot
therapi
larg
bodi
inform
avail
guidanc
appropri
outcom
measur
drug
howev
recent
studi
also
done
nonantibiot
regimen
intranas
steroid
control
trial
need
show
drug
safeti
use
label
condit
provid
substanti
evid
efficaci
recommend
use
assess
safeti
drug
much
depend
agent
drug
class
trial
evalu
alreadi
approv
medic
new
indic
need
much
less
focu
safeti
trial
new
molecular
entiti
drug
first
class
prospect
choic
end
point
critic
part
drug
develop
efficaci
end
point
trial
form
basi
approv
clinic
relev
valid
direct
also
method
use
make
measur
accur
precis
reproduc
respons
choic
efficaci
end
point
earlier
develop
might
differ
might
even
surrog
end
point
depend
phase
develop
goal
studi
rational
decis
make
limit
experi
cr
studi
statist
signific
differ
placebo
import
demonstr
initi
clinic
relev
might
difficult
quantifi
clinic
meaning
effect
could
time
reduc
recov
symptom
receiv
studi
drug
versu
placebo
rather
outcom
certain
time
point
number
potenti
problem
exist
design
rhinosinus
studi
recent
lack
consensu
regard
classif
definit
variou
type
rhinosinus
inabl
diagnos
rhinosinus
high
specif
vari
standard
care
factor
make
design
effect
clinic
studi
difficult
mani
respect
acut
rhinosinus
recurr
rhinosinus
easier
studi
cr
stage
set
refin
definit
cr
propos
document
develop
consensu
definit
cr
chronic
rhinosinus
task
forc
sinu
allergi
health
partnership
acut
rhinosinus
studi
evid
efficaci
depend
drug
adjunct
therapi
studi
need
show
combin
better
regimen
experiment
agent
ad
standalon
nonantibiot
drug
studi
need
show
experiment
medic
better
placebo
standalon
antibiot
drug
studi
need
show
experiment
antimicrobi
agent
similar
superior
approv
antibiot
well
show
evid
bacteriolog
cure
wwwfdacder
guidanc
acut
bacteri
sinus
acut
bacteri
rhinosinus
studi
clinic
outcom
measur
clinic
cure
clinic
failur
exampl
differ
antibiot
placebo
outcom
end
day
therapi
microbiolog
outcom
describ
document
erad
presum
erad
document
persist
presum
persist
recurr
rhinosinus
studi
efficaci
variabl
includ
time
recurr
possibl
primari
variabl
sever
recurr
secondari
variabl
frequenc
recurr
secondari
variabl
final
import
determin
end
point
use
assess
efficaci
care
select
avoid
confound
factor
investig
need
defin
clinic
signific
differ
particular
studi
way
defin
clinic
signific
differ
includ
distributionbas
approach
standard
respons
mean
effect
size
prefer
anchorbas
approach
use
global
rate
chang
follow
consensu
definit
diseas
classif
acut
rhinosinus
cr
without
nasal
polyposi
cr
nasal
polyposi
classic
afr
well
suggest
studi
scheme
separ
definit
outlin
research
patient
care
import
keep
mind
consensu
recommend
base
experi
author
assum
repres
posit
regulatori
bodi
complet
final
much
work
need
done
definit
rhinosinus
trial
scheme
establish
therefor
futur
panel
plan
defin
refin
appropri
clinic
trial
committe
decid
consensu
accept
term
rhinosinus
instead
sinus
throughout
document
sinus
almost
alway
accompani
concurr
nasal
airway
inflamm
mani
case
sinus
preced
rhiniti
symptom
therefor
use
term
rhinosinus
accur
describ
spectrum
infecti
inflammatori
condit
previous
group
term
sinus
group
agre
endors
adopt
previous
develop
definit
sinu
allergi
health
partnership
task
forc
follow
definit
rhinosinus
rhinosinus
group
disord
character
inflamm
mucosa
nose
paranas
sinus
although
particip
recogn
advantag
use
term
rhinosinus
rather
sinus
committe
also
want
emphas
term
rhinosinus
intend
confus
replac
term
rhiniti
refer
variou
diseas
primarili
exclus
confin
nose
import
maintain
distinct
rhinosinus
rhiniti
diagnost
therapeut
even
though
condit
might
overlap
symptom
sign
instanc
although
use
antibiot
might
appropri
case
acut
rhinosinus
would
unusu
rhinopathi
health
care
profession
keenli
awar
problem
overus
antibiot
upper
respiratori
tract
infect
commit
ad
greater
precis
diagnosi
acut
rhinosinus
cr
promulg
definit
propos
meet
expert
field
need
continu
stress
distinguish
featur
rhinosinus
import
appli
target
diagnost
criteria
make
therapeut
decis
defin
rhinosinus
well
determin
criteria
requir
secur
aforement
diagnos
mani
factor
consid
includ
tempor
natur
disord
clinic
present
imag
data
histopatholog
find
caus
factor
eg
microorgan
aspirin
sensit
allergi
differ
therapi
follow
section
discuss
research
definit
clinic
trial
guidelin
agre
upon
group
consensu
committe
member
condit
entranc
diagnost
criteria
outlin
includ
pattern
symptom
defin
particular
classif
typic
symptom
necessari
diagnos
diseas
measur
object
criteria
requir
condit
defin
typic
appear
commun
might
encompass
clinic
scenario
encount
eg
immunocompromis
host
measur
monitor
progress
determin
clinic
efficaci
also
provid
evalu
includ
monitor
individu
symptom
rate
global
symptom
sever
assess
qol
document
object
clinic
trial
find
rate
global
respons
treatment
summari
clinic
trial
guidelin
found
tabl
xviii
acut
presum
bacteri
rhinosinus
acut
rhinosinus
inflammatori
condit
involv
paranas
sinus
well
line
nasal
passag
last
week
day
immunocompet
person
live
gener
commun
acut
rhinosinus
typic
believ
induc
virus
requir
antibiot
first
day
unless
complic
featur
present
point
bacteria
presum
involv
antibiot
often
employ
complic
featur
includ
sever
headach
facial
pain
high
fever
impend
actual
complic
eye
lung
brain
without
complic
featur
present
day
symptom
consist
rhinosinus
object
find
bacteria
presum
predomin
patient
might
benefit
initi
appropri
antibiot
therapi
patient
acut
rhinosinus
typic
present
vari
degre
follow
symptom
anterior
purul
drainag
posterior
purul
drainag
plu
nasal
obstruct
facial
painpressureful
rel
nasal
inflamm
hyposmia
present
purul
aris
sinonas
passag
must
present
ensur
diagnosi
natur
predomin
organ
virus
bacteria
fungi
immunocompromis
host
intens
care
unit
patient
consid
variabl
patient
target
popul
definit
clinic
trial
recommend
research
criteria
diagnosi
patient
acut
presum
bacteri
rhinosinus
must
symptom
present
minimum
day
maximum
day
addit
individu
pattern
might
qualifi
inclus
patient
sever
diseas
presenc
nasal
postnas
purul
secret
day
high
fever
patient
whose
symptom
initi
regress
worsen
within
first
day
symptom
requir
diagnosi
includ
anterior
purul
drainag
posterior
purul
drainag
plu
nasal
obstruct
facial
painpressurefullj
allergi
clin
immunol
volum
number
ness
patient
experi
orbit
cellulit
intracrani
extens
infect
requir
hospit
consid
sever
diseas
exclud
automat
clinic
trial
uncompl
acut
presum
bacteri
rhinosinus
object
document
diagnosi
requir
either
nasal
airway
examin
purul
drainag
radiograph
evid
acut
rhinosinus
purul
drainag
note
beyond
nasal
vestibul
mean
either
anterior
rhinoscopi
endoscopi
posterior
pharyng
drainag
regard
imag
plain
sinu
film
although
certainli
less
costli
limit
gener
less
reliabl
ct
mri
might
adequ
acut
rhinosinus
studi
b
measur
monitor
progress
research
set
individu
symptom
includ
outcom
monitor
includ
drainag
anterior
posterior
nasal
obstruct
facial
painpressureful
diminish
sens
smell
headach
ear
painpressur
halitosi
dental
painpressur
cough
fatigu
fever
sleep
disturb
individu
symptom
rate
set
categor
scale
symptom
sever
also
rate
global
scale
exampl
patient
ask
overal
bother
symptom
option
respons
would
follow
bother
bother
littl
bother
littl
lot
bother
lot
extrem
bother
although
standard
subject
qol
measur
play
import
role
assess
drug
effect
clinic
trial
consensu
agreement
whether
mandat
qol
assess
trial
acut
presum
bacteri
rhinosinus
sever
object
evalu
use
monitor
efficaci
physic
examin
essenti
object
document
also
provid
basi
either
nasal
airway
examin
purul
drainag
beyond
nasal
vestibul
mean
either
anterior
rhinoscopi
endoscopi
posterior
pharyng
drainag
imag
mean
plain
radiographi
ct
anoth
object
measur
might
use
obtain
assess
bacteri
cultur
bacteri
cultur
strongli
recommend
studi
antibiot
treatment
provid
valuabl
inform
therapeut
trial
acut
bacteri
rhinosinus
final
research
use
patient
subject
global
rate
respons
treatment
exampl
respons
question
overal
would
rate
respons
treatment
patient
could
answer
use
categor
scale
follow
bad
lot
wors
littl
wors
littl
wors
littl
better
littl
better
lot
better
good
inflammatori
condit
involv
paranas
sinus
well
line
nasal
passag
persist
beyond
week
diagnosi
cr
without
nasal
polyposi
requir
symptom
must
present
week
follow
symptom
present
cr
might
strongli
suspect
anterior
mucopurul
drainag
posterior
mucopurul
drainag
nasal
obstruct
facial
painpressureful
decreas
sens
smell
object
document
requir
mean
direct
visual
middl
meatu
anterior
rhinoscopi
decongest
nasal
endoscopi
assert
accur
diagnosi
cr
bilater
np
record
absent
present
middl
meatu
distinguish
crswnp
crssnp
although
physic
examin
could
reveal
unilater
polyposi
could
repres
crswnp
unilater
appear
alway
herald
suspicion
invert
papilloma
sinonas
tumor
thu
clinic
set
imag
studi
strongli
consid
see
absenc
polyp
sign
inflamm
discolor
mucu
blood
edema
middl
meatu
ethmoid
area
must
seen
assert
diagnosi
cr
posit
sinu
ct
scan
requir
research
definit
crssnp
crswnp
rare
incident
imag
find
use
make
diagnosi
cr
independ
symptom
physic
examin
imag
studi
alon
might
abl
determin
presenc
absenc
polyp
research
criteria
diagnosi
crssnp
symptom
must
present
week
two
follow
symptom
requir
diagnosi
anterior
mucopurul
drainag
posterior
mucopurul
drainag
nasal
obstruct
facial
painpressureful
requir
object
document
requir
endoscopi
exclud
presenc
np
document
sign
inflamm
discolor
mucu
edema
middl
meatu
ethmoid
area
posit
imag
studi
mean
sinu
ct
also
requir
see
imag
section
criteria
set
forth
b
measur
monitor
progress
crssnp
individu
symptom
includ
end
point
monitor
drainag
anterior
posterior
nasal
obstruct
facial
painpressureful
diminish
sens
smell
headach
ear
painpressur
halitosi
dental
painpressur
cough
fatigu
fever
sleep
disturb
individu
symptom
rate
set
categor
scale
global
symptom
sever
also
rate
outlin
section
acut
presum
bacteri
rhinosinus
valid
qol
measur
perform
monitor
progress
option
recommend
instrument
includ
rsdi
sever
object
measur
use
determin
efficaci
physic
examin
essenti
object
document
requir
repeat
endoscopi
sinu
ct
scan
group
reach
consensu
particular
endoscop
radiograph
score
system
potenti
use
object
measur
might
use
includ
nasal
patenc
measur
must
interpret
light
lung
function
peak
nasal
inspiratori
flow
pnif
acoust
rhinometri
rhinomanometri
smell
identif
test
quantif
test
measur
mucociliari
function
assess
cytolog
pattern
measur
inflammatori
factor
nasal
mucu
epitheli
sampl
final
research
use
patient
subject
global
rate
respons
treatment
outlin
section
acut
presum
bacteri
rhinosinus
c
research
criteria
diagnosi
crswnp
definit
patient
diagnosi
cr
nasal
polyposi
requir
presenc
symptom
week
two
follow
symptom
individu
symptom
includ
end
point
monitor
drainag
anterior
posterior
nasal
obstruct
facial
painpressureful
diminish
sens
smell
headach
ear
painpressur
halitosi
dental
painpressur
cough
fatigu
fever
sleep
disturb
individu
symptom
rate
categor
scale
global
symptom
sever
also
rate
outlin
previous
valid
qol
measur
perform
group
reach
consensu
questionnair
use
monitor
progress
option
recommend
instrument
includ
rsdi
sever
object
measur
use
monitor
efficaci
physic
examin
essenti
requir
object
measur
includ
endoscopi
assess
magnitud
np
imag
also
perform
mean
ct
measur
chang
extent
diseas
nasal
patenc
measur
must
interpret
light
lung
function
pnif
acoust
rhinometri
rhinomanometri
might
also
use
object
measur
might
use
includ
smell
identif
test
smell
quantif
test
measur
mucociliari
function
assess
cytolog
pattern
measur
inflammatori
factor
nasal
mucu
epitheli
sampl
final
patient
subject
global
rate
respons
treatment
includ
outlin
previous
afr
clinic
diagnos
meet
criteria
cr
without
polyp
demonstr
presenc
allerg
mucin
evid
fungal
hypersensit
mean
skin
test
vitro
blood
test
posit
fungal
cultur
characterist
ct
studi
absenc
tissu
invas
immunocompet
host
requir
secur
diagnosi
howev
test
cultur
ct
patholog
recommend
complet
evalu
patient
anecdot
report
patient
becom
immunocompromis
afr
condit
could
predispos
patient
acut
invas
fungal
rhinosinus
research
criteria
diagnosi
classic
afr
diagnosi
afr
requir
symptom
must
present
week
one
follow
symptom
requir
diagnosi
anterior
nasal
drainag
posterior
nasal
drainag
nasal
obstruct
decreas
sens
smell
facial
painpressureful
requir
object
document
includ
endoscopi
document
presenc
inflamm
edema
middl
meatu
ethmoid
area
np
critic
establish
diagnosi
afr
identif
allerg
mucin
histolog
contain
fungal
hypha
degranul
eosinophil
imag
studi
mean
either
ct
mri
requir
occasion
show
pathognomon
featur
afr
less
case
consist
group
agre
sinu
ct
mri
find
sinu
mucos
diseas
sinu
opacif
must
present
stage
preoper
featur
need
present
postop
might
appli
instanc
drug
treatment
trial
case
diseas
clearli
present
surgeri
criteria
diseas
met
requir
criteria
includ
evid
fungalspecif
ige
mean
skin
test
vitro
blood
test
absenc
histolog
evid
invas
fungal
diseas
sinu
tissu
potenti
use
requir
diagnost
criteria
includ
posit
fungal
cultur
result
sinu
mucu
increas
total
serum
ige
level
imag
one
techniqu
ct
mri
b
measur
monitor
progress
classic
afr
individu
symptom
includ
outcom
monitor
drainag
anterior
posterior
nasal
obstruct
facial
painpressureful
diminish
sens
smell
headach
ear
painpressur
halitosi
dental
painpressur
cough
fatigu
fever
sleep
disturb
individu
symptom
rate
set
scale
global
symptom
sever
also
rate
outlin
previous
valid
qol
measur
perform
monitor
progress
option
recommend
instrument
includ
rsdi
although
standard
qol
assess
includ
group
reach
consensu
one
specif
instrument
sever
object
measur
assess
use
determin
efficaci
physic
examin
essenti
object
assess
includ
endoscopi
review
initi
describ
characterist
grade
appear
np
group
reach
consensu
particular
endoscop
score
system
imag
mean
ct
mri
also
repeat
group
reach
consensu
imag
score
system
potenti
use
object
measur
includ
use
nasal
patenc
measur
must
interpret
light
lung
function
pnif
acoust
rhinometri
rhinomanometri
smell
identif
test
smell
quantif
test
mucociliari
function
assess
cytolog
pattern
measur
inflammatori
factor
nasal
mucu
epitheli
sampl
respons
treatment
global
rate
score
includ
outlin
previous
definit
summar
tabl
xix
differ
research
definit
term
object
document
requir
diagnosi
explain
acut
presum
bacteri
rhinosinus
object
criteria
research
definit
cr
without
nasal
polyposi
clinic
diagnosi
sinu
ct
imag
essenti
strongli
consid
symptom
find
equivoc
sinu
ct
scan
confirm
diagnosi
rare
incident
imag
find
use
make
diagnosi
cr
independ
symptom
physic
examin
imag
studi
alon
might
abl
determin
presenc
absenc
polyp
sinu
ct
imag
essenti
highli
recommend
tendenc
boni
eros
extens
diseas
adjac
anatom
area
confer
focus
develop
definit
clinic
trial
design
classif
rhinosinus
encompass
larg
number
patient
howev
guidelin
still
need
refin
develop
popul
includ
patient
acut
presum
viral
rhinosinus
unresolv
subacut
rhinosinus
recurr
acut
rhinosinus
acut
exacerb
cr
eosinophil
fungal
rhinosinus
furthermor
benefit
risk
variou
intervent
focu
proceed
rhinosinus
complex
understand
still
limit
develop
sound
clinic
trial
target
variou
caus
help
clinician
gain
better
understand
effect
prevent
treat
detriment
health
consequ
associ
rhinosinus
